Abst,Sent,Source,Output,Simp. sent,Simp. term,Simp. term acc.,Simp. fluency
Q1_A4,1,Purpose: To determine predictors of best-corrected postoperative visual acuity (VA) in patients who underwent surgical intervention for macula-off rhegmatogenous retinal detachment.,"The study's purpose is to find predictors of best-corrected post-surgery visual acuity (VA) - or vision health corrected with lenses - in patients who had surgery for macula-off rhegmatogenous retinal detachment, or detachment of the retina from the eye involving the center of the retina (macula).",-1,1,1,0
Q1_A4,2,Materials and methods: Primary macula-off retinal detachments from the University of Colorado Primary Rhegmatogenous Retinal Detachment Database (2012-2017) were reviewed.,We reviewed macula-off retinal detachments from the University of Colorado Primary Rhegmatogenous Retinal Detachment Database (2012-2017).,0,0,0,1
Q1_A4,3,The primary outcome measure was a postoperative VA of 20/40 or better at least 6 months after surgery.,The main outcome measure was a post-surgery VA of 20/40 or better at least 6 months after surgery.,0,0,0,1
Q1_A4,4,"Patient demographics, medical history, duration of central vision loss before surgery, examination findings, operative technique, and postoperative findings were analyzed as possible predictors of postoperative visual recovery to 20/40 or better.","We analyzed patient characteristics, medical history, duration of central vision loss (vision loss in the center of the visual field) before surgery, exam findings, surgery technique, and post-surgery results as possible predictors of post-surgery visual recovery to 20/40 or better.",0,1,1,0
Q1_A4,5,"Chi-square or Fisher's exact test was used to compare categorical variables, and Wilcoxon rank sum test was used for continuous variables.",Certain statistics were used to compare different types of measurements.,1,0,1,1
Q1_A4,6,A multivariable logistic regression analysis was used to determine the adjusted odds ratios and 95% confidence intervals for variables that were significant in the univariable analyses.,We analyzed the likelihood for different variables.,1,0,1,1
Q1_A4,8,Results: One hundred thirty-one patients met inclusion criteria.,131 patients were included.,1,1,1,0
Q1_A4,9,Eighty-one (61.8%) patients achieved a postoperative VA of 20/40 or better 6 or more months after surgery.,81 (61.8%) patients had a post-surgery VA of 20/40 or better 6 or more months after surgery.,0,0,0,1
Q1_A4,10,"Patients with a single retinal break were more likely than patients with more than one break to reach a postoperative VA of 20/40 or better (76.9% vs. 55.4%, p = 0.021).",Patients with a single retinal tear or damage were more likely than patients with more than one tear to reach a post-surgery VA of 20/40 or better (76.9% vs. 55.4%).,1,1,1,0
Q1_A4,11,Patients with a better preoperative logMAR VA had better postoperative VA (p = 0.021).,Patients with a better pre-surgery VA had better post-surgery VA.,1,1,1,1
Q1_A4,12,Duration of central vision loss prior to surgical repair was not related to final postoperative VA in this particular study.,Duration of central vision loss before surgical repair was not related to final post-surgery VA in this study.,0,1,1,1
Q1_A4,13,Conclusion: Postoperative recovery of visual acuity to 20/40 or better was significantly more common in patients with a single retinal break as well as in patients with better preoperative visual acuity.,"In conclusion, post-surgery recovery of visual health to 20/40 or better was more common in patients with a single retinal tear and in patients with better pre-surgery visual health.",1,1,1,1
Q1_A4,14,Duration of central vision loss prior to surgical repair was not significantly associated with postoperative VA.,Duration of central vision loss before surgical repair was not linked with post-surgery VA.,0,1,1,1
Q2_A6,1,Background: Our primary objective was to determine the rate of persistent Trichomonas infection among pregnant women posttreatment.,"For the study's background, our main aim was to find the rate of persistent infection of Trichomonas (a parasite that causes sexually transmitted diseases) among pregnant women after treatment.",-1,1,1,1
Q2_A6,2,The secondary objective was to determine if oral multidose metronidazole was associated with fewer cases of persistent Trichomonas compared with single-dose treatment.,The secondary aim was to find if by-mouth multidose metronidazole (an antibiotic for infections) was associated with fewer cases of persistent Trichomonas compared with single-dose treatment.,-1,1,1,1
Q2_A6,3,Methods: This is a retrospective cohort study of women diagnosed with genital Trichomonas vaginalis from 2008 to 2017.,"For the study's methods, this study reviews women diagnosed with gential (or linked with the vagina) Trichomonas vaginalis from 2008 to 2017.",0,1,1,1
Q2_A6,4,We calculated the rate of persistent Trichomonas by dividing the number of positive Trichomonas tests collected 21 days or longer posttreatment by the total number of women treated and retested.,We measured the rate of persistent Trichomonas by dividing the number of tests detecting Trichomonas collected 21 days or longer after treatment by the total number of women treated and retested.,-1,1,1,1
Q2_A6,5,Bivariate analysis was performed to compare the rates of positive tests after single and multidose metronidazole.,We analyzed and compared rates of tests detecting Trichomonas after single and multidose metronidazole.,1,1,1,1
Q2_A6,6,Multivariate logistic regression was used to evaluate factors associated with persistent infection.,We also analyzed factors linked with lasting infection.,1,1,1,1
Q2_A6,7,Results: Five hundred forty-two women with 565 pregnancies were diagnosed with Trichomonas infection.,"For the study's results, 542 women with 565 pregnancies were diagnosed with Trichomonas infection.",1,1,1,1
Q2_A6,8,The majority of subjects were prescribed either single-dose (n = 352) or multidose metronidazole (n = 74).,The majority of subjects were given either single-dose (352 patients) or multidose metronidazole (74 patients).,1,0,1,1
Q2_A6,9,Posttreatment Trichomonas tests were collected 21 days or longer in 326 subjects and 44% (143) were positive.,We collected Trichomonas tests after treatment 21 days or longer in 326 subjects. 44% (143) detected Trichomonas.,1,1,1,1
Q2_A6,10,"Rates of positive Trichomonas tests among women receiving single-dose and multidose regimens were similar (45% vs. 40%, P = 0.50).",Rates of tests detecting Trichomonas among women receiving single-dose and multidose treatments were similar (45% vs 40%).,1,0,1,1
Q2_A6,11,"Women who had ≥1 pregnancy affected by Trichomonas infection were more likely to have a positive test posttreatment (adjusted odds ratio, 20.1; 95% confidence interval, 1.9-215.3).",Women who had a pregnancy affected by Trichomonas infection were more likely to have a test detecting Trichomonas after treatment.,1,1,1,1
Q2_A6,12,"Obese women were less likely to have a positive test posttreatment (adjusted odds ratio, 0.3; 95% confidence interval, 0.1-0.9).",Obese women were less likely to have a pregnancy affected by Trichomonas after treatment.,1,1,0,1
Q2_A6,13,"Conclusions: Given high rates of positive Trichomonas tests and increased detection with nucleic acid amplification tests (NAATs), all pregnant women should be retested with NAATs approximately 3 weeks posttreatment.","In conclusion, given high rates of tests detecting Trichomonas and increased detection with genetic testing, all pregnant women should be retested via genetic testing around 3 weeks after treatment.",-1,1,1,1
Q2_A6,14,Further studies are needed to determine the most effective treatment of Trichomonas infection in pregnant women.,More studies are needed to find the most effective treatment of Trichomonas infection in pregnant women.,1,1,1,1
Q3_A10,1,Objective: To assess the effect on hemostasis parameters of a new combined oral contraceptive (COC).,"The study's objective is to measure the effect on hemostasis or bleeding-preventing factors of a new combined oral (by-mouth) contraceptive (COC), a birth control pill to help prevent pregnancies.",-1,1,1,1
Q3_A10,2,"Study design: In this randomized, single centre, open-label, exploratory study, healthy women received either 15 mg estetrol/3 mg drospirenone (E4/DRSP) (n = 39), 30 mcg ethinylestradiol/150 mcg levonorgestrel (EE/LNG) (n = 30), or 20 mcg ethinylestradiol/3 mg drospirenone (EE/DRSP) (n = 32) for six 28-day cycles.","In this study design, healthy women were randomly grouped to receive a variety of different birth control medications for six 28-day cycles. The groups included  15 milligrams (mg) estetrol/3 mg drospirenone (E4/DRSP) (39 women), 30 micrograms (mcg) ethinylestradiol/150 mcg levonorgestrel (EE/LNG) (30 women), or 20 mcg ethinylestradiol/3 mg drospirenone (EE/DRSP) (32 women)",0,0,0,1
Q3_A10,3,"Blood was collected at baseline, cycle 3, and cycle 6.","We collected blood at start, cycle 3, and cycle 6.",0,1,1,1
Q3_A10,4,"Median change from baseline was evaluated for procoagulant, anticoagulant, and fibrinolytic parameters, and for sex hormone-binding globulin (SHBG).","We evaluated average change from start for a variety of bleeding-preventing factors and for sex hormone-binding globulin (SHBG), a marker of sex hormone amount.",1,1,1,1
Q3_A10,5,"Results: Median change of endogenous thrombin potential (ETP) based activated protein C sensitivity resistance (APCr) at cycle 6 was +30% for E4/DRSP, +165% for EE/LNG (p-value <0.05 vs E4/DRSP), and +219% for EE/DRSP (p-value <0.05 vs E4/DRSP).","For the study's results, the average change for a coagulation or bleeding-prevention test at cycle 6 was +30% for E4/DRSP, +165% for EE/LNG, which was much higher than E4/DRSP, and +219% for EE/DRSP, which was much higher than vs E4/DRSP.",0,1,1,1
Q3_A10,6,"Changes to prothrombin fragment 1 + 2 and SHBG for E4/DRSP, EE/LNG, and EE/DRSP were +23%, +71%, and +64% (p-value <0.05 vs E4/DRSP); and +55%, +74% and +251% (p-value <0.05 vs E4/DRSP), respectively.","Changes to coagulation proteins for E4/DRSP, EE/LNG, and EE/DRSP were +23%, +71%, and +64% (much higher than E4/DRSP); and +55%, +74% and +251% (much higher than E4/DRSP), respectively",0,1,1,1
Q3_A10,7,"At cycle 6, changes to other hemostasis parameters for E4/DRSP were similar or smaller than for EE/LNG or EE/DRSP.","At cycle 6, changes to other bleeding-prevention factors for E4/DRSP were similar or smaller than EE/LNG or EE/DRSP.",1,1,1,1
Q3_A10,8,"Conclusions: In this study, changes in hemostasis parameters after treatment with 6 cycles of E4/DRSP were smaller or similar to those observed for EE/LNG.","In conclusion, changes in hemostasis factors for this study after treatment with 6 cycles of E4/DRSP were small or similar to those of EE/LNG.",0,0,0,1
Q3_A10,9,"Similar, but more pronounced changes were also observed versus EE/DRSP, which supports the hypothesis that the effect of COCs on hemostasis parameters is mainly mediated by the estrogenic component.","We also saw similar, but more marked changes vs EE/DRSP, which supports the idea that the effect of COCs on bleeding-prevention factors is mainly influenced by the component regarding estrogen, a sex hormone.",1,1,1,1
Q3_A10,10,Further studies are needed to provide more insight into the venous thromboembolic risk of E4/DRSP.,More studies are needed to understand the bleeding risk of E4/DRSP.,1,0,0,1
Q3_A10,11,Implications statement: This study reports that the effects on hemostasis parameters of a COC containing 15 mg E4/3 mg DRSP are less or similar to those for EE/LNG or EE/DRSP.,This study reports that the effects of hemostasis factors of a COC with 15 mg E4/3 mg DRSP are less or similar to those for EE/LNG or EE/DRSP.,0,0,0,1
Q3_A10,12,It also demonstrates that the choice of estrogen modulates the effects of COCs on hemostasis parameters.,This study also shows that the choice of estrogen influences the effects of COCs on bleeding factors.,1,1,1,1
Q4_A4,1,"Purpose: This study investigated the prevalence, location, and severity of neck and shoulder pain (NSP), its disturbance of quality of life (QOL), and the factors related to NSP in Japanese postpartum women.","The purpose of this study was to explore the ate, location, and severity of neck and shoulder pain (NSP), how it disturbs quality of life (QOL), and the factors related to NSP in Japanese postpartum (post-childbirth) women.",0,1,1,0
Q4_A4,2,Materials and methods: The study involved 308 postpartum women who had a medical examination one month after delivery.,"For the study's methods, it involved 308 postpartum women who had a medical exam one month after delivery.",0,0,1,1
Q4_A4,3,The questionnaire consisted of the background and details of NSP.,The questionnaire included background and details of NSP.,1,1,1,1
Q4_A4,4,"Mood states were evaluated using the Profile of Mood States-Brief (POMS-B), Japanese Version.","We checked mood using the questionnaire called the Profile of Mood States-Brief (POMS-B), Japanese Version.",1,1,1,1
Q4_A4,5,"Results: The prevalence of NSP was 73.1%, one-fourth of which occurred after birth.","For the study's results, the rate of NSP was 73.1%, one-fourth of which occurred after birth.",0,1,1,1
Q4_A4,6,The most common area was the superior part of the trapezium muscles.,The most common area was the upper back muscles.,1,1,1,1
Q4_A4,7,"Prevalence was associated with past history of premenstrual syndrome (PMS), anemia during pregnancy, time per breastfeeding, and the mean POMS-B Fatigue score.","Rate was associated with past history of premenstrual syndrome (PMS: a symptom with irritability, bloating, and fatigue in women), lack of blood during pregnancy, time per breastfeeding, and the average POMS-B Fatigue score.",0,1,0,1
Q4_A4,8,"Total breastfeeding time a day, the mean POMS-B score for Fatigue, Confusion, Anger-Hostility, and Depression were significantly higher for ""worse"" after birth than those for ""no-change/relief"".","Total breastfeeding time a day, the average POMS-B score for Fatigue, Confusion, Anger-Hostility, and Depression were higher for ""worse"" (on QOL) after birth than those for ""no-change/relief"".",0,1,1,1
Q4_A4,9,The disturbance of daily life due to NSP in postpartum women with past history of PMS and Hiesho were significant higher than that for women without those.,The disturbance of daily life due to NSP in postpartum women with past history of PMS and Hiesho (sensitivity to cold) were higher than that for women without those.,1,0,1,1
Q4_A4,10,Conclusions: The prevalence of NSP in postpartum women was very high.,"In conclusion, the rate of NSP in postpartum women was very high.",1,1,1,1
Q4_A4,11,"The factors which affect NSP were the mental states, breastfeeding, past history of PMS, and anemia during pregnancy.","Mental states, breastfeeding, past history of PMS, and lack of blood during pregnancy affect NSP.",1,1,0,1
Q5_A4,1,"Importance: There is considerable public and scientific debate as to whether screen use helps or hinders early child development, particularly the development of language skills.","For the study's importance, there  is much debate whether screen use helps or hurts early child development, especially regarding language skills.",0,0,0,0
Q5_A4,2,"Objective: To examine via meta-analyses the associations between quantity (duration of screen time and background television), quality (educational programming and co-viewing), and onset of screen use and children's language skills.","The study's objective is to analyze the links between amount of screen time and background TV, educational viewing, and start of screen use and children's language skills.",1,1,1,1
Q5_A4,3,"Data sources: Searches were conducted in MEDLINE, Embase, and PsycINFO in March 2019.",We searched multiple online databases in March 2019.,1,1,1,1
Q5_A4,4,The search strategy included a publication date limit from 1960 through March 2019.,The search included a limit of published studies ranging from 1960 to March 2019.,0,0,0,0
Q5_A4,5,Study selection: Inclusion criteria were a measure of screen use; a measure of language skills; and statistical data that could be transformed into an effect size.,"We included studies measuring screen use, language skills, and data that could be analyzed.",1,1,1,1
Q5_A4,6,Exclusion criteria were qualitative studies; child age older than 12 years; and language assessment preverbal.,"We excluded studies without numbers, with child age older than 12 years, and language tests before speech developed.",0,1,0,1
Q5_A4,7,"Data extraction and synthesis: The following variables were extracted: effect size, child age and sex, screen measure type, study publication year, and study design.","We analyzed differences between groups, child age and sex, screen measure type, study publication year, and study design.",1,1,0,1
Q5_A4,8,All studies were independently coded by 2 coders and conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.,2 experts independently analyzed all studies in accordance with official guidelines.,1,1,1,1
Q5_A4,9,"Main outcomes and measures: Based on a priori study criteria, quantity of screen use included duration of screen time and background television, quality of screen use included co-viewing and exposure to educational programs, and onset of screen use was defined as the age children first began viewing screens.","Based on previous studies, amount of screen use included duration of screen time and background TV. Quality of screen use included viewing educational programs. Onset of screen use was the age children first began viewing screens.",1,1,1,1
Q5_A4,10,The child language outcome included assessments of receptive and/or expressive language.,We assessed child language with tests of language expressed with sounds and gestures.,1,1,1,1
Q5_A4,11,Results: Participants totaled 18 905 from 42 studies included.,We included 18.905 participants from 42 studies.,1,1,1,1
Q5_A4,12,Effect sizes were measured as correlations (r).,We analyzed differences between groups as associations.,0,1,1,1
Q5_A4,13,"Greater quantity of screen use (hours per use) was associated with lower language skills (screen time [n = 38; r = -0.14; 95% CI, -0.18 to -0.10]; background television [n = 5; r = -0.19; 95% CI, -0.33 to -0.05]), while better-quality screen use (educational programs [n = 13; r = 0.13; 95% CI, 0.02-0.24]; co-viewing [n = 12; r = 0.16; 95% CI, 0.07-.24]) were associated with stronger child language skills.","More screen use (hours per use) was linked with lower language skills. Bacgkround TV co-viewing, while more educational, was linked with stronger child language skills.",1,1,1,0
Q5_A4,14,"Later age at screen use onset was also associated with stronger child language skills [n = 4; r = 0.17; 95% CI, 0.07-0.27].",Later age of screen use onset was linked with stronger child language skills.,1,1,1,1
Q5_A4,15,"Conclusions and relevance: The findings of this meta-analysis support pediatric recommendations to limit children's duration of screen exposure, to select high-quality programming, and to co-view when possible.","In conclusion, this analysis supports recommendations to limit children's screen time, to select high-quality educational shows, and view shows with them when possible.",1,1,1,1
Q6_A4,1,Animal-assisted intervention is gaining attention as a stress reduction modality.,Animal-assisted intervention may be a stress reduction treatment.,1.0,0.0,0.0,1.0
Q6_A4,2,"Quantitative data demonstrate its effectiveness, as a recent study published in AJHPM supported that a Veterans Affairs (VA) hospital facility dog paired with a palliative care psychologist had a measurable impact on salivary cortisol levels and heart rate in hospitalized veterans.","Numerical data shows its effectiveness. A recent study supported that a Veterans Affairs (VA) hospital dog paired with a palliative care psychologist impacts cortisol levels (measured via saliva) and heart rate in hospitalized veterans. Palliative care is treatment to improve quality of life for those with serious, end-of-life diseases.",1.0,0.0,1.0,1.0
Q6_A4,3,There remains an important role for qualitative insights.,There is still a place for non-numerical findings.,1.0,1.0,1.0,1.0
Q6_A4,4,"The Denver VA palliative care team learned a range of lessons from the sudden loss of their facility dog, many of which relate directly to palliative care.",The Denver VA palliative care team learned many lessons from the sudden loss of their facility dog. Many of the lessons relate to palliative care.,1.0,1.0,1.0,1.0
Q6_A4,5,"The importance of communication, adjusting to changing teams, and the need for consultation and support based in shared goals and values all became evident in the course of the facility dog's illness.","Communication, adjusting to changing teams, and the need for consultation and support regarding shared goals and values became evident in the course of the facility dog's illness.",0.0,1.0,1.0,1.0
Q6_A4,6,"After her death, lessons shifted to grief and loss and how providers, patients, and a community care for each other.","After her death, lessons shifted to grief, loss, and how providers, patients, and a community care for each other.",0.0,1.0,1.0,1.0
Q6_A4,7,People's connection to the facility dog ultimately proved to be a critical factor in helping them connect with one another.,People's connection to the dog was a critical factor in helping them connect with each other.,1.0,0.0,1.0,1.0
Q7_A3,1,Background: To examine our initial experience in carotid stenting (CS) for the prevention of stroke in patients with high-grade carotid stenoses.,The study's background is to check our initial experience in carotid stenting (CS) to prevent stroke in patients with severe carotid stenoses. Carotid stenting is a procedure involving inserting a mesh tube into the stenosis or narrowed blood vessel bringing blood to the head or neck.,1,1,1,1
Q7_A3,2,Methods: The authors performed 26 CS procedures in 25 carotid vessels in 22 patients over a 15-month period.,We did 26 CS procedures in 25 carotid vessels in 22 patients over 15 months.,1,1,1,1
Q7_A3,3,"All carotid stenoses treated, except one, were 70% or greater.","All carotid stenoses treated, but one, were 70% or greater.",1,1,1,1
Q7_A3,4,"Of all CS procedures, 84% were performed for obstructing atherosclerotic plaques.","Of all CS procedures, we performed 84% for blocking atherosclerotic plaques, or buildup of fats and cholesterol.",1,1,1,1
Q7_A3,5,"CS was performed in one patient each for carotid dissection and pseudoaneurysms caused by a gunshot wound, post-radiation stenosis, post-carotid endarterectomy (CEA) restenosis, and a flow-obstructing post-CEA intimal flap.","We performed CS in 1 patient each for carotid dissection (cutting into the blood vessel) and pseudoaneurysms (in which the blood vessel wall is damaged) caused by a gunshot wound, post-radiation stenosis, post-carotid endarterectomy (CEA) restenosis, and a flow-blocking post-CEA internal flap. CEA is surgical removal of the lining of the blood vessel along with plaque buildup.",-1,-1,-1,1
Q7_A3,6,"Of all patients, 68.2% were symptomatic, with a history of stroke or transient ischemic attacks ipsilateral to the treated carotid artery.","68.2% of all patients showed symptoms, with a history of stroke or mini strokes on the same side as the treated carotid artery or blood vessel supplying blood to the head and neck.",1,1,1,1
Q7_A3,7,"In addition, 36.4% of our patients were either hospitalized or required skilled nursing care before CS because of severe neurologic deficits.","Also, 36.4% of our patients were either hospitalized or required skilled nursing before CS because of severe brain-related deficits.",0,0,0,1
Q7_A3,8,"Using the Sundt CEA-risk classification system, 59.1% of our patients were classified as Grade III and 40.9% were Grade IV pre-CS.","Using official classification guidelines, 59.1% of patients were classified as Grade III (severe) and 40.9% were Grade IV (very severe) pre-CS.",1,1,1,1
Q7_A3,9,All but one patient had either a compelling medical or anatomic reason for endovascular treatment of their carotid disease.,All but one patient had either a compelling medical or physical reason for treatment of their carotid disease via tubes within blood vessels.,0,0,0,1
Q7_A3,10,"We used both Wallstents and Palmaz stents, and all procedures were performed via the transfemoral route.",We used two types of tools to open blood vessels. We perforemd all procedures above the knee.,1,1,1,1
Q7_A3,11,"Three procedures were performed in conjunction with detachable platinum coil embolization for multiple carotid pseudoaneurysms, a residual carotid ""stump"" after previous ICA thrombosis, and an ipsilateral MCA saccular aneurysm.","We performed 3 procedures with detachable platinum coil blockage for multiple carotid pseudoaneurysms, a lasting carotid ""stump"" after previous ICA thrombosis or blood clotting, and a same-side MCA saccular aneurysm (bulging of a blood vessel in the head on one side).",0,0,0,0
Q7_A3,12,Results: We had a 96.2% procedural technical success rate.,"For results, we had a 96.2% success rate.",0,0,0,1
Q7_A3,13,There was one death in our series 3 weeks post-CS attributable to myocardial infarction.,There was one death in our series 3 weeks post-CS due to myocardial infarction (lack of oxygen to the heart).,1,1,1,1
Q7_A3,14,"Despite a high 30-day combined death, stroke, and ipsilateral blindness rate of 27.3% (6/22 patients), only two ipsilateral strokes directly related to CS occurred (7.7% per procedures performed) from which one patient recovered fully within 5 days.","Despite a high 30-day combined death, stroke, and same-side blindness rate of 27.3% (6/22 patients), only two same-side strokes directly related to CS occurred (7.7% per procedures performed). Of this, one patient recovered fully within 5 days.",1,1,1,1
Q7_A3,15,"The average follow-up post-CS was 5.9 months (range, 3 weeks-15 months).",The average follow-up post-CS was 5.9 months.,0,0,0,0
Q7_A3,16,"Of successfully treated vessels, 58.3% have undergone 6-month follow-up vascular imaging, which has revealed a 14.3% rate of occlusion or restenosis greater than 50%.","Of successfully treated vessels, 58.3% have undergone 6-month follow-up blood-vessel imaging. Thisshowed a 14.3% rate of blockage or re-narrowing greater than 50%.",0,0,0,1
Q7_A3,17,"At or beyond 1 month post-CS, 19 of 21 surviving patients (90.5%) were ambulatory, fluent of speech, and independent, and none has thus far suffered a delayed stroke or TIA.","At or beyond 1 month post-CS, 19 of 21 surviving patients (90.5%) were able to walk, fluent of speech, and independent. None had thus far suffered a delayed stroke or mini-stroke.",1,1,1,1
Q7_A3,18,Conclusion: CS seems to be a reasonable alternative to medical management for the treatment of carotid disease in patients deemed to be poor candidates for standard carotid surgery.,"In conclusion, CS may be an alternative to medical management to treat carotid disease in patients deemed poor candidates for standard carotid surgery.",0,0,0,1
Q7_A3,19,Longer term follow-up is necessary to assess the durability of carotid revascularization using CS.,We need longer follow-up to measure the durability of carotid blood flow improvement using CS.,1,1,1,1
Q8_A1,1,"The frequency and severity of 17 side effects presumably associated with stimulant medication were assessed during a rigorous, triple-blind, placebo-controlled, crossover evaluation of methylphenidate, 0.3 and 0.5 mg/kg twice a day, in 83 children with attention deficit hyperactivity disorder.","We measured the frequency and severity of 17 side effects apparently linked with stimulant (drugs which speed up the function of the brain and spinal cord). We did this through a detailed study of methylphenidate (a stimulant used to treat those with attention deficit hyperactivity disorder), 0.3 and 0.5 milligrams (mg)/kilogram (kg) twice a day, in 83 children with attention deficit hyperactivity disorder.",0.0,0.0,1.0,1.0
Q8_A1,2,Side effects were rated by parents and teachers at the end of each weekly drug condition.,Parents and teachers rated side effects each week.,1.0,1.0,1.0,1.0
Q8_A1,3,Three children (3.6%) had side effects that were sufficiently serious to warrant immediate discontinuation of medication.,Three children (3.6%) had side effects that were serious enough to stop use of the medication.,1.0,1.0,1.0,1.0
Q8_A1,4,"Parent ratings indicated that only the side effects of decreased appetite, insomnia, stomachaches, and headaches increased significantly in frequency and severity during the two active medication doses as compared with the placebo condition.","Parent ratings showed that only the side effects of decreased appetite, insomnia (inability to fall asleep), stomachaches, and headaches increased in frequency and severity with medication compared to placebo condition (sham-treatment group).",-1.0,1.0,1.0,1.0
Q8_A1,5,"Fewer than half of the children experienced these side effects and among those who did, ratings of mean severity remained in the mild range.","Fewer than half of the children had these side effects. For those who did, ratings of average severity were in the mild range.",1.0,1.0,1.0,1.0
Q8_A1,6,"Teacher ratings showed little change over drug conditions, except on ratings of staring, sadness, and anxiety, which declined with increasing dose of medication.","Teacher ratings showed little change over drug conditions, except on ratings of staring, sadness, and anxiety, which declined with higher medication doses.",0.0,1.0,1.0,1.0
Q8_A1,7,"Parent ratings indicated that only the side effects of decreased appetite, insomnia, stomachaches, and headaches increased significantly in frequency and severity during the two active medication doses as compared with the placebo condition.","Parent ratings showed that only the side effects of decreased appetite, insomnia (inability to fall asleep), stomachaches, and headaches increased in frequency and severity with medication compared to placebo condition (sham-treatment group).",-1.0,1.0,1.0,1.0
Q8_A1,8,"Fewer than half of the children experienced these side effects and among those who did, ratings of mean severity remained in the mild range.","Fewer than half of the children had these side effects. For those who did, ratings of average severity were in the mild range.",1.0,1.0,1.0,1.0
Q8_A1,9,"Teacher ratings showed little change over drug conditions, except on ratings of staring, sadness, and anxiety, which declined with increasing dose of medication.","Teacher ratings showed little change over drug conditions, except on ratings of staring, sadness, and anxiety, which declined with higher medication doses.",0.0,1.0,1.0,1.0
Q8_A1,10,"Surprisingly, a high frequency of these behavior side effects were reported during the placebo condition.","Surprisingly, many of these behavior side effects were reported during the placebo condition.",1.0,1.0,1.0,1.0
Q8_A1,11,"Stimulant medication within this therapeutic range, therefore, results in few, generally mild side effects.","Thus, stimulant medication within this treatment range results in few, generally mild side effects.",1.0,0.0,1.0,1.0
Q9_A8,1,Background and objectives: Probiotics have been widely used for host immune system enhancement but with limited knowledge regarding the immunomodulation mechanisms by which they assist the mucosal innate immune response.,"For the study's background and objectives, probiotics (microorganisms that usually help the body when consumed or applied) have been used to enhance the host immune system but with limited knowledge regarding how they assist the first-line mucosal immune response or immune response lining the organs.",-1,0,1,1
Q9_A8,2,"We investigated the effects of probiotics on the modulation of the innate mucosal immune response particularly in association with Toll-like receptor (TLR)-2, TLR-4 and nuclear factor-kappa B (NF-κB) p65 and p105.","We explored the effects of probiotics on how they influence the first-line mucosal immune response, especially with specific cell receptors and proteins.",0,0,0,1
Q9_A8,3,Materials and methods: We randomized 24 male BALB/c mice into four groups.,"For methods, we randomized 24 male, albino, lab-bred mice into four groups.",0,1,1,1
Q9_A8,4,Two groups were administered probiotics for 21 consecutive days; one of these groups was challenged with Lipopolysaccharide (LPS) on day 15.,We gave probiotics to two groups for 21 consecutive days. We infected one of these groups with the toxin Lipopolysaccharide (LPS) on day 15.,0,0,0,1
Q9_A8,5,The third group was challenged with only LPS.,We infected the third group with only LPS.,0,1,1,1
Q9_A8,6,The fourth group remained untreated.,The fourth group remained untreated.,1,1,1,1
Q9_A8,7,All mice were sacrificed after 21 days.,All mice were sacrificed after 21 days.,1,1,1,1
Q9_A8,8,"An immunohistochemistry procedure on the ileum was performed and monoclonal antibodies specific for TLR-2, TLR-4 and NF-κB p65 and p105 were used for the analysis of innate lymphoid cells.",We stained of the small intesine tissue. We used antibodies tagging specific cell receptors and proteins to analyze first-line lymphoid cells (immune cells that fight viruses and bacteria).,-1,0,0,0
Q9_A8,9,"Results: In the LPS-only treated group, there was a significant decrease in p105, indicating an alternative transcription pathway for the process of pro-inflammatory cytokine production.","For results, in the LPS-only treated group, the protein p105 decreased, showing an alternative pathway to process pro-inflammatory chemical signal production.",0,0,0,0
Q9_A8,10,In the probiotics-only treated group there was significant enhancement of TLR-2 and TLR-4 and NF-κB p65 and p105.,"In the probiotics-only treated group, the receptors TLR-2 and TLR-4 and the proteins NF-κB p65 and p105 increased.",0,0,0,1
Q9_A8,11,"When mice treated with probiotics were exposed to LPS, there was a significant decrease in NF-κB p65 and p105, indicating employment of the classical pathway for pro-inflammatory cytokine production.","When mice treated with probiotics were exposed to LPS, NF-κB p65 and p105 decreased, indicating use of the traditional pathway for pro-inflammatory chemical signal production.",0,0,0,1
Q9_A8,12,Conclusion: Probiotics can enhance the innate mucosal immune response in healthy mice and can maintain the homeostasis of the gut mucosal immune response against LPS through the activation of the classical NF-κB pathway.,"In conclusion, probiotics can enhance the first-line mucosal immune response in healthy mice and maintain the balance of the gut mucosal immune response against LPS by activating the traditional NF-κB pathway.",0,0,0,1
Q10_A9,1,"Objective: Does short-term cryotherapy improve pain, function and quality of life in people with knee osteoarthritis (OA)?","The study's objective is to determine if short-term cryotherapy (cold therapy) improves pain, function and quality of life in people with knee osteoarthritis (OA), a ""wear-and-tear"" joint disease"".",0,1,1,1
Q10_A9,2,"Design: Randomised controlled trial with concealed allocation, blinded assessment of some outcomes, and intention-to-treat analysis.",The study is designed as a randomised trial with blind grouping and assessment of some outcomes and intention-to-treat analysis.,0,0,1,1
Q10_A9,3,Participants: People living in the community with knee OA.,We included participants living in the community with knee OA.,1,1,1,1
Q10_A9,4,"Interventions: The experimental group received cryotherapy, delivered as packs of crushed ice applied to the knee with mild compression.","The treatment or experimental group received cryotherapy, delivered as packs of crushed ice applied to the knee with mild compression.",1,1,1,1
Q10_A9,5,The control group received the same regimen but with sham packs filled with sand.,The control group received the same treatment but with sham packs filled with sand.,1,1,1,1
Q10_A9,6,The interventions were applied once a day for 4 consecutive days.,We applied the treatments once a day for 4 consecutive days.,1,1,1,1
Q10_A9,7,Outcome measures: Participants were assessed at baseline and on the day after the 4-day intervention period.,We measured participants at start and on the day after the 4-day treatment period.,1,1,1,1
Q10_A9,8,The primary outcome was pain intensity according to a visual analogue scale.,The primary measure was pain intensity according to a scale.,1,1,1,1
Q10_A9,9,"Secondary outcomes were baseline to post-intervention changes according to the Western Ontario and McMaster Universities Osteoarthritis, Knee injury and Osteoarthritis Outcome; Timed Up and Go test; and 30-Second Chair to Stand test.","Secondary measures were start to post-treatment changes according to the osteoarthritis scales, knee injury scales, and mobility tests.",1,1,1,1
Q10_A9,10,Results: Sixty participants were randomised into the experimental group (n = 30) or the control group (n = 30).,"For results, we randomized 60 participants into experimental group (30 participants) or the control group (30 participants).",1,1,1,1
Q10_A9,11,Twenty-nine participants from each group completed the trial.,29 participants from each group completed the trial.,1,1,1,1
Q10_A9,12,"The mean between-group difference in change in pain severity was -0.8 cm (95% CI -1.6 to 0.1), where negative values favour the experimental group.","The average between-group difference in change in pain severity was -0.8 centimeters (cm), where negative values favour the experimental group.",1,0,1,1
Q10_A9,13,This result did not reach the nominated smallest worthwhile effect of 1.75 cm.,This result did not reach the smallest worthwhile effect of 1.75 cm.,1,0,1,1
Q10_A9,14,"The secondary outcomes had less-precise estimates, with confidence intervals that spanned worthwhile, trivial and mildly harmful effects.","The secondary measures had less-precise estimates, with statistical intervals that spanned worthwhile, trivial and mildly harmful effects.",0,1,1,1
Q10_A9,15,Conclusion: Short-term cryotherapy was not superior to a sham intervention in terms of relieving pain or improving function and quality of life in people with knee OA.,"In conclusion, short-term cryotherapy was not better than sham intervention for relieving pain or improving function and quality of life in people with knee OA.",1,1,1,1
Q10_A9,16,"Although cryotherapy is considered to be a widely used resource in clinical practice, this study does not suggest that it has an important short-term effect, when compared with a sham control, as a non-pharmacological treatment for people with knee osteoarthritis.","Although cryotherapy is widely used in clinical practice, this study does not suggest it has an effect compared with a sham control as a non-drug treatment for people with knee osteoarthritis.",1,1,1,1
Q11_A1,1,The evidence of long-term clinical dynamic on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RNA re-positive case are less.,There is not much evidence of long-term nature on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) reinfection. SARS-CoV-2 is the virus that causes the lung infection known as COVID-19.,0.0,0.0,1.0,0.0
Q11_A1,2,"We performed a 108 days follow-up on dynamic clinical presentations in a case, who hospitalized three times due to the positive recurrence of SARS-CoV-2 RNA after discharge, to understand the prognosis of the 2019-Coronavirus disease (COVID-19).","We performed a 108 days follow-up on clinical presentations in a patient, who hospitalized 3 times due to recurrence of SARS-CoV-2 after release from the hospital, to understand the recovery of the 2019-Coronavirus disease (COVID-19).",0.0,1.0,1.0,0.0
Q11_A1,3,"In this case, positive SARS-CoV-2 recurred even after apparent recovery (normal CT imaging, no clinical symptoms, negative SARS-CoV-2 on stool sample and negative serum IgM test) from COVID-19, viral shedding duration lasted for 65 days, the time from symptom onset to disappearance was up to 95 days.","In this case, SARS-CoV-2 recurred even after apparent recovery (normal imaging, no clinical symptoms, no virus detected in stool and blood samples) from COVID-19. Viral removal duration lasted for 65 days. The time from symptom start to disappearance was up to 95 days.",0.0,1.0,0.0,0.0
Q11_A1,4,"Erythrocyte-associated indicators, liver function and serum lipid metabolism presented abnormal throughout during the observation period.","Red blood cell-related indicators, liver function and blood fat metabolism were abnormal during observations.",1.0,0.0,1.0,1.0
Q11_A1,5,Awareness of atypical presentations such as this one is important to prompt the improvement of the management of COVID-19.,Awareness of abnormal presentations such as this one is important to prompt improvement of managing COVID-19.,0.0,1.0,1.0,1.0
Q12_A2,1,"The use of oral terbinafine in the treatment of superficial dermatophyte infections has been extensively studied, using different treatment regimens.","Using oral (taken-by-mouth) antifungal terbinafine to treat surface-level fungal skin infections has been extensively studied, using different treatments.",0.0,1.0,1.0,1.0
Q12_A2,2,"To evaluate the efficacy of short-term therapy with oral terbinafine in cases of tinea cruris/corporis, 22 patients (21 male and one female) with mycologically proven tinea cruris/corporis, were included in the present study.","To measure the success of short-term therapy with oral terbinafine in cases of the fungal infection tinea cruris/corporis, we included 22 patients (21 male and one female) with lab proven tinea cruris/corporis in the present study.",-1.0,0.0,1.0,1.0
Q12_A2,3,Each patient received one tablet of terbinafine 250 mg daily for 1 week.,Each patient received one tablet of terbinafine 250 milligrams (mg) daily for 1 week.,1.0,0.0,1.0,1.0
Q12_A2,4,Patients were followed-up for 6 weeks after completion of treatment.,We followed up with patients for 6 weeks after finishing treatment.,1.0,1.0,1.0,1.0
Q12_A2,5,"Clinical and mycological assessments were performed at the end of treatment, and at the end of the follow-up period.",We performed clinical and biological measurements at the end of treatment and the follow-up period.,1.0,0.0,1.0,1.0
Q12_A2,6,"The mean sum of scores of signs and symptoms in all patients decreased significantly from 12.36 before treatment to 0 at the end of the follow-up period, and mycological investigations were negative in all patients at the end of the follow-up period.",The average sum of symptoms scores in all patients decreased from before treatment to at the end of the follow-up period. Biological checks showed no infection in all patients at the end of the follow-up.,1.0,1.0,1.0,1.0
Q12_A2,7,Our results show that 1-week therapy with oral terbinafine is highly effective in the treatment of tinea cruris/corporis.,Our results show that 1-week therapy with oral terbinafine is highly effective to treat tinea cruris/corporis.,1.0,1.0,1.0,1.0
Q13_A7,1,Abdominal aortic aneurysm (AAA) is defined as a permanent dilatation of the abdominal aorta that exceeds 3 cm.,Abdominal aortic aneurysm (AAA) is a permanent ballooning of the abdominal aorta (a blood vessel that carries blood from the heart to the rest of the body) that exceeds 3 centimeters (cm).,1.0,1.0,1.0,1.0
Q13_A7,2,Most AAAs arise in the portion of abdominal aorta distal to the renal arteries and are defined as infrarenal.,Most AAAs occur in the part of the aorta around the blood vessels of the kidney and are called infrarenal.,1.0,1.0,1.0,1.0
Q13_A7,3,Most AAAs are totally asymptomatic until catastrophic rupture.,Most AAAs show no symptoms until a damaging rupture.,1.0,1.0,1.0,1.0
Q13_A7,4,The strongest predictor of AAA rupture is the diameter.,The strongest predictor of AAA rupture is the diameter.,1.0,1.0,1.0,1.0
Q13_A7,5,Surgery is indicated to prevent rupture when the risk of rupture exceeds the risk of surgery.,Surgery helps prevent rupture when the risk of rupture exceeds the risk of surgery.,1.0,1.0,1.0,1.0
Q13_A7,6,"In this review, we aim to analyze this disease comprehensively, starting from an epidemiological perspective, exploring etiology and pathophysiology, and concluding with surgical controversies.","In this review article, we aim to analyze this disease in detail, including how it spreads, how it is caused, its symptoms, and debates about surgical procedures.",1.0,1.0,1.0,1.0
Q13_A7,7,We will pursue these goals by addressing eight specific questions regarding AAA: (1) Is the incidence of AAA increasing? (2) Are ultrasound screening programs for AAA effective? (3) What causes AAA: Genes versus environment? (4) Animal models: Are they really relevant? (5) What pathophysiology leads to AAA? (6) Indications for AAA surgery: Are surgeons over-eager to operate? (7) Elective AAA repair: Open or endovascular? (8) Emergency AAA repair: Open or endovascular?,We pursue these goals by answering 8 questions about AAA: (1) Is the number of AAA increasing? (2) Are ultrasound screening programs for AAA effective? (3) What causes AAA: Genes versus environment? (4) Animal models: Are they really useful? (5) What causes leads to AAA? (6) Indications for AAA surgery: Are surgeons over-eager to operate? (7) AAA repair by choice: Open (surgery with large cuts for full-view) or endovascular (surgery with smaller cuts to only access the blood vessels)? (8) Emergency AAA repair: Open or endovascular?,1.0,1.0,1.0,1.0
Q14_A1,1,"Idiopathic pulmonary fibrosis (IPF) is an incurable condition that is characterized by progressive pulmonary fibrosis, architectural distortion of the lung and loss of gas exchange units.","Idiopathic pulmonary fibrosis (IPF) is an incurable condition of progressive scarring of the lungs, lung structure degradation, and loss of lung function.",1.0,1.0,1.0,1.0
Q14_A1,2,"Until recently, there was no effective treatment for this condition.","Until recently, there was not treatment for IPF.",1.0,1.0,1.0,1.0
Q14_A1,3,"However, there were two landmark trials published earlier this year, which have changed the management of this condition.","However, management of IPF has changed with two trials published this year.",1.0,1.0,1.0,1.0
Q14_A1,4,Pirfenidone (Assessment of Pirfenidone to Confirm Efficacy and Safety in Idiopathic Pulmonary Fibrosis trial) and nintedanib (Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis-1 and -2 trials) have both demonstrated positive outcomes in patients with IPF.,"The anti-lung-scarring medication, pirfenidone (used in the trial titled ""Assessment of Pirfenidone to Confirm Efficacy and Safety in Idiopathic Pulmonary Fibrosis"") and nintedanib (used in the trial titled ""Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis-1 and -2""), have helped IPF patients.",-1.0,1.0,1.0,1.0
Q14_A1,5,"In this perspective, we critically discuss the role of these agents in IPF and in the broader pulmonary fibrosis population.","In this article, we discuss the role of these agents in IPF and lung scarring in general.",1.0,1.0,1.0,1.0
Q15_A1,1,"Objectives: We compared the semiquantitative measurement of acetoacetate using urinary dipsticks with the bedside quantitative fingerprick measurement of the principal ketone bodies 3-beta-hydroxybutyrate, for the diagnosis of ketoacidosis.","For study objectives, we compared acetoacetate (a product of fat breakdown) using urinary dipsticks with the bedside fingerprick measurement of ketone bodies 3-beta-hydroxybutyrate (another product of fat breakdown), for the diagnosis of ketoacidosis. Ketoacidosis is a state of high levels of ketones - molecules created from fat breakdown.",1,1,1,1
Q15_A1,2,Methods: This is a one year retrospective study of patients who presented with hyperglycemia levels of 250 mg/l or greater in the Emergency Department setting.,This one-year study explores patients with hyperglycemia (high blood sugar) levels of 250 milligrams (mg)/liter (l) or greater in the Emergency Department.,1,1,1,1
Q15_A1,3,"We compared the sensitivity, specificity, and predictive value of ketonuria and ketonemia for the diagnosis of ketoacidosis (urine or blood ketone bodies, blood bicarbonates <20 mmol/l, anion gap >16 meq/l) in a sample of patients for whom the levels of ketone bodies in the blood and urine as well as serum electrolytes were available.","We compared the sensitivity (ability to identify patients with the disease), specificity (ability to identify patients without the disease), and predictive value of ketonuria (large amounts of ketones in urine) and ketonemia (large amounts of ketones in blood) to diagnose ketoacidosis (urine or blood ketone bodies) in patients for whom the levels of ketone bodies in the blood and urine and blood electrolytes were available.",1,1,1,1
Q15_A1,4,Results: We studied 355 hyperglycemic patients.,"For results, we studied 355 hyperglycemic patients.",1,1,1,1
Q15_A1,5,"The median time between arrival and dipstick testing was 21 min, and was greater than 2 h in more than 10% of cases.",The average time between arrival and dipstick testing was 21 min. It was greater than 2 hours (h) in more than 10% of cases.,0,1,1,1
Q15_A1,6,Comparison between ketonuria and ketonemia was performed in 173 patients (6% with diabetic ketoacidosis).,We compared ketonuria and ketonemia in 173 patients (6% with diabetic ketoacidosis or ketoacidosis tied to diabetes).,0,1,1,1
Q15_A1,7,Ketonuria equal to or less than one cross or a 3-beta-hydroxybutyrate value lower than 3 mmol/l enabled ketoacidosis to be excluded (negative predictive value 100%).,Ketonuria at or below a certain level called cross or 3-beta-hydroxybutyrate value lower than 3 millimol (mmol)/l enabled ketoacidosis to be excluded (negative predictive value 100%).,0,0,1,0
Q15_A1,8,"At two-cross cutoff points for ketonuria and at the 3 mmol/l cutoff point for ketonemia, the two tests had the same sensitivity (100%), but the specificity of 3-beta-hydroxybutyrate (94%) was significantly higher (P<0.0001) than that of ketonuria (77%).","At two-cross cutoff points for ketonuria and at the 3 mmol/l cutoff point for ketonemia, the two tests had the same sensitivity (100%), but the specificity of 3-beta-hydroxybutyrate (94%) was higher than that of ketonuria (77%).",0,1,1,1
Q15_A1,9,The best positive predictive value for ketonemia was obtained at the 5 mmol/l cutoff point (100%) and for ketonuria at the three-cross cutoff point (26%).,We obtained the best positive predictive value for ketonemia at the 5 mmol/l cutoff point (100%) and for ketonuria at the three-cross cutoff point (26%).,0,1,1,1
Q15_A1,10,"At the three-cross cutoff point for ketonuria and at the 5 mmol/l cutoff point for ketonemia, the two tests had the same negative likelihood ratio (0.1), but the positive likelihood ratio of 3-beta-hydroxybutyrate (infinite) was higher than that of ketonuria.","At the three-cross cutoff point for ketonuria and at the 5 mmol/l cutoff point for ketonemia, the two tests had the same negative likelihood ratio (0.1). However, the positive likelihood ratio of 3-beta-hydroxybutyrate was higher than that of ketonuria.",0,0,1,1
Q15_A1,11,Conclusion: The measurement of 3-beta-hydroxybutyrate in capillary blood is faster and more effective than the use of dipsticks in the urine to detect ketoacidosis in the Emergency Department setting.,"In conclusion, testing 3-beta-hydroxybutyrate via blood is faster and more effective than using dipsticks in urine to detect ketoacidosis in the Emergency Department.",1,1,1,1
Q16_A2,1,Factors other than the glomerular filtration rate (GFR) can affect creatinine clearance (Ccr) and serum creatinine concentration (Pcr).,"Factors other than the filtration of blood into the kidneys, known as the glomerular filtration rate (GFR), can affect creatinine clearance (Ccr) and blood creatinine concentration (Pcr), clearnances of a waste product.",-1,1,1,1
Q16_A2,2,The effect of dietary protein and antihypertensive therapy on Ccr the reciprocal of the Pcr (1/Pcr).,"We measured the effect of dietary protein and anti-high-blood-pressure treatment on Ccr, the inverse of Pcr (1/Pcr), and what they affect (GFR, creatinine clearance from tubular secretion (CTScr) in the kidney, and creatinine excretion (UcrV) from urine values) in patients participating in the Modification of Diet in Renal (kidney) Disease (MDRD) Study.",-1,-1,0,0
Q16_A2,4,This study compared the effects of assignment to a low versus usual-protein diet and to a low versus usual-blood pressure goal on the decline in these measurements over 3 yr in 585 patients with baseline GFR of 25 to 55 mL/min per 1.73 m2 (Study A).,This study compared the effects of assignment to a low vs usual-protein diet and to a low vs usual-blood pressure goal on the decline in these measurements over 3 years (yr) in 585 patients with starting GFR of 25 to 55 milliliters (mL)/minute (min) per 1.73 m2 (meter squared) (Study A).,-1,1,1,0
Q16_A2,5,"This study also assessed correlations and associations of these measurements with each other and with protein intake, blood pressure, class of antihypertensive agents, and renal diagnosis in 840 patients with baseline GFR of 13 to 55 mL/min per 1.73 m2 (Studies A and B).","This study also measured associations of these measurements with each other and with protein intake, blood pressure, class of anti-high-blood-pressure treatments, and kidney diagnosis in 840 patients with starting GFR of 13 to 55 mL/min per 1.73 m2 (Studies A and B).",-1,0,1,1
Q16_A2,6,"In Study A, the estimated mean decline in GFR at 3 yr did not differ significantly between the low and usual-protein diet groups (-10.9 versus -12.1 mL/min).","In Study A, the estimated average GFR decline at 3 yr did not differ between the low and usual-protein diet groups (-10.9 versus -12.1 mL/min).",0,0,1,1
Q16_A2,7,"In contrast, CTScr declined more in the low-protein diet group (-7.8 versus -3.6 mL/min, P < .05).","In contrast, CTScr declined more in the low-protein diet group (-7.8 versus -3.6 mL/min).",1,0,1,1
Q16_A2,8,"Consequently, the low-protein diet group had a greater decline in Ccr (-17.6 versus -14.4 mL/min, P < .05).","As a result, the low-protein diet group had a greater decline in Ccr (-17.6 versus -14.4 mL/min).",1,0,1,1
Q16_A2,9,"The low-protein diet group also had a greater decline in UcrV (-306 versus -92 mg/day, P < .05).",The low-protein diet group also had a greater decline in UcrV (-306 versus -92 milligrams or mg/day).,1,0,1,0
Q16_A2,10,"The decline in UcrV was proportionately greater than the decline in CTScr hence the decline in 1/Pcr was less in the low-protein diet group (-0.091 versus -0.122 dl/mg, P < .05).","The decline in UcrV was proportionately greater than the decline in CTScr. Thus, the decline in 1/Pcr was less in the low-protein diet group (-0.091 versus -0.122 dl/mg).",1,-1,1,1
Q16_A2,11,"Similarly, in Study A, there was no significant difference in the decline in GFR at 3 yr between the low and usual-blood pressure groups (-10.7 versus -12.3 mL/ min).","Similarly, in Study A, there was no difference in GFR decline at 3 yr between the low and usual-blood pressure groups (-10.7 versus -12.3 mL/ min).",0,-1,1,1
Q16_A2,12,"However, there was a lesser decline in CTScr in the low blood pressure group (-4.7 versus -6.7 mL/ min, P < .05).","However, there was a lesser decline in CTScr in the low blood pressure group (-4.7 versus -6.7 mL/ min).",0,-1,1,1
Q16_A2,13,"Consequently, the decline in Ccr was less in the low blood pressure group (-14.2 versus -17.8 mL/min, P < .05).","Consequently, the decline in Ccr was less in the low blood pressure group (-14.2 versus -17.8 mL/min).",0,-1,1,1
Q16_A2,14,There was no significant difference in UcrV between the blood pressure groups (-192 versus -205 mg/day).,There was no difference in UcrV between the blood pressure groups (-192 versus -205 mg/day).,0,-1,1,1
Q16_A2,15,"Hence, the decline in 1/Pcr paralleled the decline in Ccr; it was less in the low blood pressure group (-0.091 versus -0.122 dL/mg, P < .05).","Thus, the decline in 1/Pcr paralleled the decline in Ccr. It was less in the low blood pressure group (-0.091 versus -0.122 deciliter dL/mg).",1,-1,1,1
Q16_A2,16,"In Studies A and B, correlations of rates of decline in Ccr and GFR were 0.64 and 0.79, respectively (P < 0.001).","In Studies A and B, correlations of rates of decline in Ccr and GFR were 0.64 and 0.79, respectively.",0,-1,1,1
Q16_A2,17,"Correlations of rates of decline in 1/Pcr and GFR were 0.79 and 0.85, respectively (P < 0.001).","Correlations of rates of decline in 1/Pcr and GFR were 0.79 and 0.85, respectively.",1,-1,1,1
Q16_A2,18,"In Studies A and B combined, baseline GFR, CTScr and UcrV correlated significantly with protein intake (r = 0.45, 0.47, and 0.36, respectively; P < 0.001), but not with blood pressure.","In Studies A and B combined, starting GFR, CTScr and UcrV was linked with protein intake, but not with blood pressure.",0,0,1,1
Q16_A2,19,"Baseline CTScr was significantly lower in patients with polycystic kidney disease and tubulointerstitial diseases or urinary tract diseases, compared with glomerular and other diseases (P < 0.05).","Starting CTScr was lower in patients with certain kidney or bladder diseases like polycystic kidney disease and tubulointerstitial diseases or urinary tract diseases, compared with kidney diseases like glomerular and other diseases.",-1,0,1,1
Q16_A2,20,"It was also lower in patients who were taking calcium channel blockers, compared with patients not taking these agents, and in patients not taking diuretics, compared with patients taking diuretics (P < 0.05).","It was also lower in patients who were taking calcium channel blockers (common blood pressure medications), compared with patients not taking these treatments. It was lower in patients not taking diuretics, compared with patients taking diuretics.",1,1,1,1
Q16_A2,21,These results show that creatinine secretion and excretion are affected by protein intake.,These results show that creatinine secretion and excretion are affected by protein intake.,1,-1,1,1
Q16_A2,22,Creatinine secretion is also affected by antihypertensive therapy and renal diagnosis.,Creatinine secretion is also affected by anti-high-blood-pressure treatment and kidney diagnosis.,1,0,0,1
Q16_A2,23,"In the MDRD Study, the low-protein diet reduced creatinine secretion and excretion, and the low blood pressure goal slowed the decline in creatinine secretion.","In the MDRD Study, the low-protein diet reduced creatinine secretion and excretion. The low blood pressure goal slowed the decline in creatinine secretion.",1,1,1,1
Q16_A2,24,These effects caused differences between the diet groups and between the blood pressure groups in Ccr and 1/Pcr that were not the result of differences in GFR.,These effects caused differences between the diet groups and between the blood pressure groups in Ccr and 1/Pcr that were not from differences in GFR.,0,-1,1,1
Q16_A2,25,Studies assessing the effects of these interventions on the progression of renal disease should measure GFR in addition to Ccr and Pcr.,"Studies measuring the effects of these treatments on the progression of kidney disease should measure GFR, Ccr, and Pcr.",1,0,1,1
Q17_A4,1,The realization that low-glycemic index diets were formulated using resistant starch led to more than a decade of research on the health effects of resistant starch.,That low-glycemic index or low-blood-sugar-spiking diets were created using resistant starch led to over a decade of research on the health effects of resistant starch.,0.0,0.0,1.0,0.0
Q17_A4,2,Determination of the metabolizable energy of the resistant starch product allowed for the performance of isocaloric studies.,Isocaloric or same-calorie-amount diet studies help determine the metabolizable energy of the resistant starch product.,0.0,0.0,1.0,1.0
Q17_A4,3,"Fermentation of resistant starch in rodent studies results in what appears to be a healthier gut, demonstrated by increased amounts of short-chain fatty acids, an apparent positive change in the microbiota, and increased gene expression for gene products involved in normal healthy proliferation and apoptosis of potential cancer cells.","Fermenting resistant starch in rodent studies leads to a healthier gut, shown by increased amounts of short-chain or broken-up fatty acids, a positive change in the microbiota (microbiology of the gut), and increased gene expression for gene products involved in normal healthy growth and death of potential cancer cells.",0.0,0.0,1.0,1.0
Q17_A4,4,"Additionally, consumption of resistant starch was associated with reduced abdominal fat and improved insulin sensitivity.","Also, consuming resistant starch was linked with reduced ab fat and improved insulin sensitivity.",0.0,0.0,1.0,1.0
Q17_A4,5,Increased serum glucagon-like peptide 1 (GLP-1) likely plays a role in promoting these health benefits.,Increased blood glucagon-like peptide 1 (GLP-1) - a protein segment involved in metabolism - likely helps promote these health benefits.,0.0,0.0,1.0,1.0
Q17_A4,6,One rodent study that did not use isocaloric diets demonstrated that the use of resistant starch at 8% of the weight of the diet reduced body fat.,One rodent study not using isocaloric diets showed that the use of resistant starch at 8% of the weight of the diet reduced body fat.,0.0,0.0,0.0,1.0
Q17_A4,7,This appears to be approximately equivalent to the human fiber requirement.,This is around the same as the human fiber requirement.,1.0,1.0,1.0,1.0
Q17_A4,8,"In human subjects, insulin sensitivity is increased with the feeding of resistant starch.","In human subjects, insulin sensitivity is increased with eating resistant starch.",0.0,0.0,1.0,1.0
Q17_A4,9,"However, only 1 of several studies reports an increase in serum GLP-1 associated with resistant starch added to the diet.","However, only 1 of many studies notes an increase in blood GLP-1 linked with resistant starch added to the diet.",1.0,1.0,1.0,1.0
Q17_A4,10,"This means that other mechanisms, such as increased intestinal gluconeogenesis or increased adiponectin, may be involved in the promotion of improved insulin sensitivity.","This means other mechanisms, like increased intestinal gluconeogenesis (creation of glucose) or increased adiponectin (a signaling hormone released from fat to help regulate insulin), may be involved in promoting improved insulin sensitivity.",1.0,1.0,1.0,1.0
Q17_A4,11,Future research may confirm that there will be improved health if human individuals consume the requirement for dietary fiber and a large amount of the fiber is fermentable.,Future research may confirm that there will be improved health if human individuals eat the requirement for dietary fiber and a large amount of the fiber is fermentable.,0.0,0.0,1.0,0.0
Q18_A2,1,Background: The current experiment investigated the impact of two potential confounding variables on the postural balance in young participants: the induced-experimental activity prior to the static postural measurements and the well-documented time-of-day effects.,"As background, the current experiment explored the impact of two possible factors affecting other factors on the postural balance in young participants. These two factors are the experimental activity before static postural measurements and the effect from the time-of-day.",1.0,0.0,0.0,0.0
Q18_A2,2,We mainly hypothesized that an exhaustive exercise and a high attention-demanding task should result in alterations of postural control.,We theorized that exhaustive exercise and a high attention-demanding task should lead to changes in postural control.,1.0,0.0,1.0,1.0
Q18_A2,3,"Methods: Ten participants performed three experimental sessions (differentiated by the activity - none, cognitive or physical - prior of the assessment of postural stability), separated by one day at least.","10 participants did 3 experimental sessions (ranging from no activity to a cognitive one to a physical one before measuring postural stability), separated by at least one day.",0.0,1.0,1.0,1.0
Q18_A2,4,"Each session included postural balance assessments around 8 a.m., 12.00 p.m. and 5 p.m. ± 30 min.","Each session measured postural balance around 8 a.m., 12.00 p.m. and 5 p.m. ± 30 min.",1.0,0.0,1.0,1.0
Q18_A2,5,The physical and cognitive activities were performed only before the 12 o'clock assessment.,We conducted the physical and cognitive activities before the 12 o'clock measurement.,1.0,1.0,1.0,1.0
Q18_A2,6,The postural tests consisted of four conditions of quiet stance: stance on a firm surface with eyes open; stance on a firm surface with eyes closed; stance on a foam surface with eyes open and stance on a foam surface with eyes closed.,The postural tests included four conditions of quiet stance: stance on a firm surface with eyes open; stance on a firm surface with eyes closed; stance on a foam surface with eyes open; and stance on a foam surface with eyes closed.,0.0,0.0,1.0,1.0
Q18_A2,7,Postural performance was assessed by various center of pressure (COP) parameters.,We measured postural performance by various center of pressure (COP) measures.,1.0,0.0,1.0,1.0
Q18_A2,8,"Results: Overall, the COP findings indicated activity-related postural impairment, with an increase in body sway in the most difficult conditions (with foam surface), especially when postural measurements are recorded just after the running exercise (physical session) or the psychomotor vigilance test (cognitive session).","Overall, the COP results showed activity-related postural impairment, with more swaying in the most difficult conditions (with foam surface). This is true especially when during postural measurements just after the physical or cognitive sessions.",1.0,0.0,1.0,1.0
Q18_A2,9,"Conclusions: Even if no specific influence of time-of-day on static postural control is demonstrated, our results clearly suggest that the activities prior to balance tests could be a potential confounding variable to be taken into account and controlled when assessing clinical postural balance.","In conclusion, even if time-of-day does not affect postural control, the activities before balance tests could affect results when measuring clinical postural balance.",1.0,1.0,1.0,1.0
Q19_A9,1,"Lennox-Gastaut syndrome (LGS), a childhood-onset severe developmental and epileptic encephalopathy (DEE), is an entity that encompasses a heterogenous group of aetiologies, with no single genetic cause.","Lennox-Gastaut syndrome (LGS), a childhood severe developmental and epileptic encephalopathy (DEE), has many different causes, with no single genetic cause. Encephalopathy is any brain disease altering brain function.",1.0,1.0,1.0,1.0
Q19_A9,2,"It is characterised by multiple seizure types, an abnormal EEG with generalised slow spike and wave discharges and cognitive impairment, associated with high morbidity and profound effects on the quality of life of patients and their families.","LGS involves multiple seizure types, an abnormal electrical signal pattern, cognitive impairment, high rate of symptoms, and profound effects on the quality of life of patients and their families.",1.0,1.0,1.0,1.0
Q19_A9,3,"Drug-refractory seizures are a hallmark and treatment is further complicated by its multiple morbidities, which evolve over the patient's lifetime.","Drug-refractory seizures (seizures unresponsive to drugs) are present. Treatment is further complicated by its multiple symptoms, which change over the patient's lifetime.",1.0,1.0,1.0,1.0
Q19_A9,4,This review provides a comprehensive overview of the current and future options for the treatment of seizures associated with LGS.,This article reviews current and future treatment options for seizures associated with LGS.,1.0,1.0,1.0,1.0
Q19_A9,5,"Six treatments are specifically indicated as adjunct therapies for the treatment of seizures associated with LGS in the US: lamotrigine, clobazam, rufinamide, topiramate, felbamate and most recently cannabidiol.","6 seizure medications are accompanying treatments of seizures associated with LGS in the US: lamotrigine, clobazam, rufinamide, topiramate, felbamate and most recently cannabidiol.",1.0,1.0,1.0,1.0
Q19_A9,6,"These therapies have demonstrated reductions in drop seizures in 15%-68% of patients across trials, with responder rates (≥ 50% reduction in drop seizures) of 37%-78%.",These therapies reduce drop seizures (seizures involving loss of muscle strength) in 15%-68% of patients across trials. Responder rates (rates with at or over 50% reduction in drop seizures) are 37%-78%.,1.0,1.0,1.0,1.0
Q19_A9,7,"Valproate is still the preferred first-line treatment, generally in combination with lamotrigine or clobazam.","Valproate is still the preferred first-choice treatment, generally used with lamotrigine or clobazam.",1.0,1.0,1.0,1.0
Q19_A9,8,"Other treatments frequently used off-label include the broad spectrum anti-epileptic drugs (AED) levetiracetam, zonisamide and perampanel, while recent evidence from observational studies has indicated that a newer AED, the levetiracetam analogue brivaracetam, may be effective and well tolerated in LGS patients.","Other treatments frequently used off-label include the broad range of anti-epileptic drugs (AED) levetiracetam, zonisamide and perampanel. A newer AED, the levetiracetam analogue brivaracetam, may be effective and well tolerated in LGS patients.",1.0,0.0,0.0,1.0
Q19_A9,9,"Other treatments in clinical development include fenfluramine in late phase III, perampanel, soticlestat-OV953/TAK-953, carisbamate and ganaxolone.","Other drug medications in development include fenfluramine in late phase III, perampanel, soticlestat-OV953/TAK-953, carisbamate and ganaxolone.",0.0,0.0,1.0,0.0
Q19_A9,10,"Non-pharmacologic interventions include the ketogenic diet, vagus nerve stimulation and surgical interventions; these are also expanding, with the potential for less invasive techniques for corpus callosotomy that have promise for reducing complications.","Non-drug treatments include the low-carb/high-fat ketogenic diet, vagus nerve stimulation (stimulation of nerves in the head and neck) and surgery. These techniques are expanding, with the possibility for less invasive techniques (less large cuts during surgery) for corpus callosotomy (an operation to cut the band connecting the two hemispheres of the brain) that may reduce complications.",1.0,1.0,1.0,1.0
Q19_A9,11,"However, despite these advancements, patients continue to experience a significant burden.","However, despite these advancements, patients continue to have a large burden.",1.0,1.0,1.0,0.0
Q19_A9,12,"Because LGS is not a single entity, tailoring of treatment is needed as opposed to a 'one size fits all' approach.","Because LGS is not one type, tailoring treatment is needed rather than a 'one size fits all' approach.",1.0,1.0,1.0,0.0
Q19_A9,13,"Further research is needed into the underlying aetiologies and pathophysiology of LGS, together with advancements in treatments that encompass the spectrum of seizures associated with this complex syndrome.","More research is needed to learn the causes and effects of LGS. Also, advancements in treatments for the range of seizures associated with this complex syndrome is needed.",1.0,1.0,1.0,1.0
Q20_A7,1,"Laron syndrome (LS), or primary growth hormone resistance, is a prototypical congenital insulin-like growth factor 1 (IGF1) deficiency.","Laron syndrome (LS), or resistance to growth hormone (a hormone used to grow and develop the body), also includes from-birth insulin-like growth factor 1 (IGF1) deficiency. IGF1 is also used to grow and develop the heart, brain, bones, and other parts of the body.",0.0,0.0,1.0,0.0
Q20_A7,2,The recent epidemiological finding that LS patients do not develop cancer is of major scientific and clinical relevance.,Recent findings that LS patients do not develop cancer is of major importance.,1.0,1.0,1.0,1.0
Q20_A7,3,Epidemiological data suggest that congenital IGF1 deficiency confers protection against the development of malignancies.,Population data suggest that from-birth IGF1 shortage leads to cancer development protection.,1.0,1.0,1.0,1.0
Q20_A7,4,This 'experiment of nature' reflects the critical role of IGF1 in tumor biology.,This 'experiment of nature' reflects the critical role of IGF1 in tumor development.,1.0,1.0,1.0,1.0
Q20_A7,5,The present review article provides an overview of recently conducted genome-wide profiling analyses aimed at identifying mechanisms and signaling pathways that are directly responsible for the link between life-time low IGF1 levels and protection from tumor development.,We review recent genetic tests aimed at identifying how life-time low IGF1 levels link to protection from tumor development.,1.0,1.0,1.0,1.0
Q20_A7,6,The review underscores the concept that 'data mining' an orphan disease might translate into new developments in oncology.,The review emphasizes the concept that 'data mining' an orphan disease might lead to cancer study developments.,1.0,0.0,1.0,1.0
Q21_A8,1,"Peripheral neuropathies are characterized by nerves damage and axonal loss, and they could be classified in hereditary or acquired forms.",Peripheral neuropathies include nerves damage and damage to the neurons. These can be hereditary or acquired.,1,0,1,1
Q21_A8,2,"Acquired peripheral neuropathies are associated with several causes, including toxic agent exposure, among which the antineoplastic compounds are responsible for the so called Chemotherapy-Induced Peripheral Neuropathy (CIPN).","Acquired peripheral neuropathies are linked with several causes, including toxic agent exposure. Among these include the antineoplastic compounds responsible for the so called Chemotherapy-Induced Peripheral Neuropathy (CIPN), nerve damage caused by chemotherapy (cancer drug treatment).",1,0,1,1
Q21_A8,3,Several clinical features are related to the use of anticancer drugs which exert their action by affecting different mechanisms and structures of the peripheral nervous system: the axons (axonopathy) or the dorsal root ganglia (DRG) neurons cell body (neuronopathy/ganglionopathy).,Several clinical factors are related to the use of anticancer drugs which work by affecting different parts of the nerves: the axons (axonopathy) - structures which send signals to other neurons - or the dorsal root ganglia (DRG) neurons cell body (neuronopathy/ganglionopathy) - a cluster of neurons.,1,1,0,0
Q21_A8,4,"In addition, antineoplastic treatments may affect the blood brain barrier integrity, leading to cognitive impairment that may be severe and long-lasting.","Also, anticancer treatments may affect the blood brain barrier structure, leading to cognitive impairment that may be severe and long-lasting.",0,0,1,1
Q21_A8,5,CIPN may affect patient quality of life leading to modification or discontinuation of the anticancer therapy.,"CIPN may affect patient quality of life, leading to modification or stoppage of the anticancer therapy.",1,1,1,1
Q21_A8,6,"Although the mechanisms of the damage are not completely understood, several hypotheses have been proposed, among which neuroinflammation is now emerging to be relevant in CIPN pathophysiology.","Although we do not know how the damage occurs, we have several theories, among which neuroinflammation may be one relevant to CIPN.",1,0,1,1
Q21_A8,7,"In this review, we consider different aspects of neuro-immune interactions in several CIPN preclinical studies which suggest a critical connection between chemotherapeutic agents and neurotoxicity.",We review different aspects of neuro-immune interactions in several CIPN studies. These suggest a connection between chemotherapeutic agents and toxicity in the nervous system.,1,0,1,1
Q21_A8,8,"The features of the neuroinflammatory processes may be different depending on the type of drug (platinum derivatives, taxanes, vinca alkaloids and proteasome inhibitors).","Neuroinflammatory process features may be different depending on the type of drug used (platinum derivatives, taxanes, vinca alkaloids and proteasome inhibitors).",0,0,1,1
Q21_A8,9,"In particular, recent studies have demonstrated an involvement of the immune response (both innate and adaptive) and the stimulation and secretion of mediators (cytokines and chemokines) that may be responsible for the painful symptoms, whereas glial cells such as satellite and Schwann cells might contribute to the maintenance of the neuroinflammatory process in DRG and axons respectively.","Recent studies have shown the immune response and immune signaling molecules may be responsible for the painful symptoms. Also, cells supporting neurons may contribute to neuroinflammatory process in neurons.",1,1,1,1
Q21_A8,10,"Moreover, neuroinflammatory components have also been shown in the spinal cord with microglia and astrocytes playing an important role in CIPN development.","Also, neuroinflammatory components have been shown in the spinal cord with certain cell types supporting neurons influencing CIPN development.",1,1,1,1
Q21_A8,11,"Taking together, better understanding of these aspects would permit the development of possible strategies in order to improve the management of CIPN.","Altogether, better understanding these aspects may lead to possible strategies that improve CIPN management.",1,1,1,1
Q22_A3,1,Chamomile is one of the most ancient medicinal herbs known to mankind.,Chamomile is an ancient medicinal herb known to mankind.,1,1,1,1
Q22_A3,2,It is a member of Asteraceae/Compositae family and represented by two common varieties viz.,It is a member of Asteraceae/Compositae (Daisy) family and represented by two common types.,1,1,1,1
Q22_A3,3,German Chamomile (Chamomilla recutita) and Roman Chamomile (Chamaemelum nobile).,Those two types are German Chamomile (Chamomilla recutita) and Roman Chamomile (Chamaemelum nobile).,1,1,1,1
Q22_A3,4,The dried flowers of chamomile contain many terpenoids and flavonoids contributing to its medicinal properties.,The dried flowers of chamomile have many terpenoids (therapeutic compounds) and flavonoids (antioxidant compounds) contributing to its medicinal properties.,1,1,1,1
Q22_A3,5,"Chamomile preparations are commonly used for many human ailments such as hay fever, inflammation, muscle spasms, menstrual disorders, insomnia, ulcers, wounds, gastrointestinal disorders, rheumatic pain, and hemorrhoids.","Chamomile preparations are commonly used for many human ailments like hay fever (seasonal allergies), inflammation, muscle spasms, menstrual disorders, insomnia, ulcers (sores), wounds, digestive disorders, arthritic pain, and hemorrhoids (swollen veins near the rectum).",1,1,1,1
Q22_A3,6,Essential oils of chamomile are used extensively in cosmetics and aromatherapy.,Essential chamomile oils are used extensively in cosmetics and aromatherapy.,1,1,1,1
Q22_A3,7,"Many different preparations of chamomile have been developed, the most popular of which is in the form of herbal tea consumed more than one million cups per day.","Many different preparations of chamomile have been developed. The most popular is herbal tea, consumed more than one million cups per day.",1,1,1,0
Q22_A3,8,"In this review we describe the use of chamomile in traditional medicine with regard to evaluating its curative and preventive properties, highlight recent findings for its development as a therapeutic agent promoting human health.","We review the use of chamomile in traditional medicine, evaluating its curative and preventive properties and highlighting how it became a therapeutic agent promoting human health.",1,1,0,1
Q23_A9,1,"This study aims to introduce a resistance training protocol (6 repetitions × 70% of 1 maximum repetition (1RM), followed by 6 repetitions × 50% of 1RM within the same set) specifically designed for postmenopausal women with osteopenia/osteoporosis and monitor the effect of the protocol on bone mineral density (BMD) in the lumbar spine, assessed by dual-energy X-ray absorptiometry (DEXA).","This study introduces a resistance training protocol: 6 repetitions × 70% of 1 maximum repetition (1RM), followed by 6 repetitions × 50% of 1RM within the same set. This protocol is designed for postmenopausal women (women who have had their last menstrual cycle) with osteopenia/osteoporosis (bone weakening disorders). We measure the protocol's effect on bone mineral density (BMD) in the lower spine via X-rays.",1.0,1.0,1.0,1.0
Q23_A9,2,"The subjects included in the study were 29 postmenopausal women (56.5 ± 2.8 years) with osteopenia or osteoporosis; they were separated into two groups: the experimental group (n = 15), in which the subjects participated in the strength training protocol for a period of 6 months; and the control group (n = 14), in which the subjects did not take part in any physical activity.","This study included 29 postmenopausal women (average age of 56.5 years) with osteopenia or osteoporosis. We separated them into two groups: the experimental group (15 women), in which the subjects did the strength training protocol for 6 months; and the control group (14 women), in which the subjects did not do any physical activity.",1.0,1.0,1.0,1.0
Q23_A9,3,BMD in the lumbar spine was measured by DEXA.,We measured BMD in the lower spine via X-rays.,1.0,1.0,1.0,1.0
Q23_A9,4,The measurements were performed at the beginning and end of the study.,We did the measurements at the beginning and end of the study.,1.0,1.0,1.0,1.0
Q23_A9,5,"A statistically significant increase (Δ% = 1.82%) in BMD was observed at the end of the study for the exercise group (0.778 ± 0.042 at baseline vs. 0.792 ± 0.046 after 6 months, p = 0.018, 95% CI [-0.025, -0.003]); while an increase was observed for the control group (Δ% = 0.14%), the difference was not statistically significant (0.762 ± 0.057 at baseline vs. 0.763 ± 0.059, p = 0.85, 95% CI [-0.013, 0.011]).","BMD increased at the end of the study for the exercise group after 6 months. While the control group's average BMD also increased was observed for the control group (Δ% = 0.14%), the increase was not significant.",0.0,1.0,1.0,0.0
Q23_A9,6,"In conclusion, our strength training protocol seems to be effective in increasing BMD among women with osteopenia/osteoporosis and represents an affordable strategy for preventing future bone loss.","In conclusion, our strength training protocol seems to increase BMD among women with osteopenia/osteoporosis. It may be an affordable strategy for preventing future bone loss.",1.0,1.0,1.0,1.0
Q24_A1,1,"Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a highly contagious virus that infects humans and a number of animal species causing coronavirus disease-19 (COVID-19), a respiratory distress syndrome which has provoked a global pandemic and a serious health crisis in most countries across our planet.","Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a highly contagious virus that infects humans and multiple animal species. The virus causes coronavirus disease-19 (COVID-19), a lung infection which led to a global pandemic and serious health crisis in most countries across the world.",1,1,1,1
Q24_A1,2,"COVID-19 inflammation is mediated by IL-1, a disease that can cause symptoms such as fever, cough, lung inflammation, thrombosis, stroke, renal failure and headache, to name a few.","COVID-19 inflammation is influenced by IL-1, a disease that can cause symptoms like fever, cough, lung inflammation, blood clotting, stroke, kidney failure and headache.",1,1,1,1
Q24_A1,3,Strategies that inhibit IL-1 are certainly helpful in COVID-19 and can represent one of the therapeutic options.,Strategies that inhibit IL-1 are helpful in COVID-19 and can represent a treatment.,1,0,1,1
Q24_A1,4,"However, until now, COVID-19 therapy has been scarce and, in many cases, ineffective, since there are no specific drugs other than the vaccine that can solve this serious health problem.","However, until now, COVID-19 treatment has been rare and, in many cases, ineffective. Besides vaccines, there is no drug to solve this serious health problem.",1,1,1,1
Q24_A1,5,"Messenger RNA (mRNA) vaccines which are the newest approach, are already available and will certainly meet the many expectations that the population is waiting for.","Messenger RNA (mRNA) vaccines (vaccines which use molecules related to DNA rather than the actual virus) are the newest approach, are already available, and will meet many expectations the population has.",-1,1,1,1
Q24_A1,6,"mRNA vaccines, coated with protected soft fatty lipids, use genetic mRNA (plus various inactive excipients) to make a piece of the coronavirus spike protein, which will instruct the immune system to produce specific antibodies.","mRNA vaccines, coated with protected soft fatty outer layers, use genetic mRNA (and various inactive parts) to make a piece of the coronavirus protein, which instructs the immune system to produce specific antibodies against the virus.",0,1,1,1
Q24_A1,7,The soft fatty lipids allow the entry of mRNA into cells where it is absorbed into the cytoplasm and initiates the synthesis of the spike protein.,The soft fatty outer layer allows the entry of mRNA into cells. it is absorbed into the cell body and starts the creation of the coronavirus protein.,1,1,1,0
Q24_A1,8,"In addition, vaccination also activates T cells that help the immune system respond to further exposure to the coronavirus.","Also, vaccination activates T cells that help the immune system respond to future exposure to the coronavirus.",1,1,1,1
Q24_A1,9,mRNA induces the synthesis of antigens of SARS-CoV-2 virus which stimulate the antibody response of the vaccinated person with the production of neutralizing antibodies.,mRNA causes the creation of components of SARS-CoV-2 virus which stimulate antibody production of the vaccinated person.,1,0,1,1
Q24_A1,10,"The new variant of the coronavirus-19 has been detected in the UK where, at the moment, the London government has imposed a lockdown with restrictions on international movements.","The new coronavirus-19 type has been detected in the UK. At the moment, the London government has imposed a lockdown with restrictions on international travel.",1,1,1,1
Q24_A1,11,"The virus variant had already infected 1/4 of the total cases and in December 2020, it reached 2/3 of those infected in the UK.","The virus type had already infected 1/4 of the total cases. In December 2020, it reached 2/3 of those infected in the UK.",1,1,1,1
Q24_A1,12,"It has been noted that the spreading rate of the British variant could be greater than 70% of cases compared to the normal SARS-CoV-2 virus, with an R index growth of 0.4.",The spreading rate of the British variant may be greater than 70% of cases compared to the normal SARS-CoV-2 virus.,1,1,1,1
Q24_A1,13,"Recent studies suggest that coronavirus-19 variation occurs at the level N501Y of the spike protein and involves 23 separate mutations on the spike, 17 of which are linked to the virus proteins, thus giving specific characteristics to the virus.","Recent studies suggest coronavirus-19 changes occurs at a specific part of the protein and involves 23 separate mutations on the protein. 17 of these mutations are linked to the virus proteins, giving specific characteristics to the virus.",1,1,1,1
Q24_A1,14,"In general, coronaviruses undergo many mutations that are often not decisive for their biological behavior and does not significantly alter the structure and the components of the virus.","In general, coronaviruses undergo many mutations that do not alter behavior, structure, and components of the virus.",1,1,1,1
Q24_A1,15,This phenomenon also occurs in SARS-CoV-2.,This phenomenon also occurs in SARS-CoV-2.,1,1,1,1
Q24_A1,16,It is highly probable that the variants recently described in the UK will not hinder vaccine-induced immunity.,It is likely that variants recently described in the UK will not block vaccine-caused immunity.,1,1,1,1
Q24_A1,17,"In fact, the variant will not break the vaccine although it may have some chance of making it a little less effective.","In fact, the variant will not break the vaccine. However, it may make it a little less effective.",1,1,1,1
Q24_A1,18,"Therefore, it is pertinent to think that the vaccine will work against the SARS-CoV-2 variant as well.","Therefore, it is relevant to think that the vaccine will work against the SARS-CoV-2 type as well.",1,1,1,1
Q24_A1,19,"In today's pandemic, the D614G mutation of the amino acid of corronavirus-19, which emerged in Europe in February 2020 is the most frequent form and causes high viral growth.","In today's pandemic, a mutation called the D614G mutation of the coronavirus-19, which occurred in Europe in February 2020, is the most frequent form and causes high viral growth.",0,0,1,1
Q24_A1,20,The previously infrequent D614G mutation is now globally dominant.,The previously infrequent D614G mutation is now globally dominant.,1,1,1,1
Q24_A1,21,"This variant, which is being tested by many international laboratories, is rapidly spreading across the countries and a series of vaccinated subjects are testing to see if their antibodies can neutralize the new variant of SARS-CoV-2.","This type, tested in many labs, is rapidly spreading across the countries and multiple vaccinated subjects are testing to see if their antibodies can neutralize the new type of SARS-CoV-2.",0,1,1,1
Q24_A1,22,This variant has a very high viral growth and is less detectable with the RT-PCR technique in the laboratory.,This variant has a very high viral growth and is less detectable with the current lab technique called RT-PCR.,1,1,1,1
Q24_A1,23,"It has been reported that the British variant that increases viral load does not cause more severe effects in the respiratory tract and lung disease, therefore, it is certain that the variant is growing rapidly and must be kept under control; for this reason, laboratory data is expected impatiently.","The British variant that increases viral amount does not cause more severe effects in the lung tract and lung disease. Thus, it is certain the variant is growing rapidly and must be kept under control. For this reason, lab data is expected impatiently.",1,1,1,1
Q24_A1,24,The study on the many variants that coronavirus-19 presents is very interesting and complete and clearer data on this topic will be ready in the near future.,Studying the various coronavirus-19 types is very interesting. Complete and clearer data on this topic will be ready in the near future.,1,1,1,1
Q24_A1,25,"In addition, it is still unclear whether the different variants discovered in many countries, including Africa, share the same spike protein mutation and therefore, this is another study to elaborate on.","Also, it is still unclear whether the different types discovered in many countries, including Africa, share the same protein mutation. This is another study to investigate.",1,1,1,1
Q24_A1,26,"In order to be certain and to not have unexpected surprises, we need to reduce the spread and the transmission speed of viral variants that could appear around the world, creating new pandemics.","To be certain, we need to lower the spread and the transmission (the process of spreading) speed of viral variants that could appear around the world, creating new pandemics.",0,1,1,0
Q24_A1,27,"For this reason, the scientific community is on the alert since laboratory tests on serum antibodies from COVID-19 survivors have been reported to be less effective in attacking the variant.","For this reason, scientists are on alert, especially since lab tests on antibodies from COVID-19 survivors are less effective in attacking the variant.",1,1,1,1
Q24_A1,28,"In light of the above, the scientific community must be on the alert as larger variants of the spike protein could escape vaccine-induced antibodies, which for now are of great help to the community and can save millions of lives.","With this fact in mind, scientists must be alert as larger variants of the protein could escape vaccine-caused antibodies, which for now aid millions of lives.",0,1,1,1
Q24_A1,29,Deepening the study of spike protein mutations will help to better understand how to combat coronavirus-19 and its variants.,More study on protein mutations will help to better understand how to combat coronavirus-19 and its variants.,1,1,1,1
Q25_A1,1,"Experimental, epidemiologic and clinical studies have provided strong evidence that physical exercise has beneficial effects on multiple physiological variables affecting cardiovascular health (lipoprotein levels, rest blood pressure and heart rate, carbohydrate tolerance, neurohormonal activity).","Lab, population, and clinical studies give strong evidence that physical exercise improves parts of heart-related (cardiovascular) health (fat-protein levels, rest blood pressure, resting heart rate, carb tolerance, brain-hormonal activity).",1,0,1,1
Q25_A1,2,Regular exercise has been shown to slow the progression of cardiovascular disease and to reduce cardiovascular morbidity and mortality.,Regular exercise can also slow the progression of cardiovascular disease and reduce cardiovascular illness and death rate.,1,1,1,1
Q25_A1,3,"More recently, exercise-induced increases in blood flow and shear stress have been observed to enhance vascular function and structure.","Recently, exercise-based increases in blood flow and shear stress can enhance blood vessel function and structure.",1,0,1,0
Q25_A1,4,"By increasing the release of nitric oxide and prostacyclin, shear stress augments endothelium-dependent vasodilation and inhibits multiple processes involved in atherogenesis and restenosis.","By increasing molecules that widen blood vessels, shear stress improves widening of blood vessels and blocks processes involved with plaque buildup in blood vessels.",1,1,1,1
Q25_A1,5,In this review we discuss the underlying mechanisms by which exercise-induced blood flow and shear stress exert their salutary effects on cardiovascular remodeling.,We review how exercise-caused blood flow and shear stress remodels blood vessels and the heart.,1,1,0,1
Q26_A2,1,Research on relationships between personality and cognitive abilities has so far resulted in inconsistent findings regarding the strength of the associations.,"So far, research exploring how personality relates to mental abilities have led to inconclusive results.",1.0,1.0,1.0,1.0
Q26_A2,2,"Moreover, relationships have rarely been compared longitudinally and bidirectionally between midlife versus late-life cohorts by considering different personality traits as well as multiple cognitive domains over a long-term follow-up period.","Also, researchers rarely compare relationships over the long-term between midlife versus late-life groups by considering different personality traits and mental domains.",1.0,1.0,1.0,1.0
Q26_A2,3,"We hypothesize that the interplay between the ""Big Five"" personality traits (Neuroticism, Extraversion, Openness to Experience, Agreeableness and Conscientiousness) and cognitive abilities (information processing speed, crystallized intelligence, fluid intelligence) may change from midlife to old age due to age-associated changes in cognitive and personality plasticity.","We hypothesize that how the ""Big Five"" personality traits (Neuroticism or mental stability, Extraversion or outgoingness, Openness to Experience, Agreeableness and Conscientiousness or diligence) and mental abilities (information processing speed, general knowledge, problem solving) may change from midlife to old age due to age-associated changes in mentality and personality.",-1.0,1.0,1.0,1.0
Q26_A2,4,"We used data from the German Interdisciplinary Longitudinal Study of Adult Development (ILSE study; n = 1,002).","We used data from the German Interdisciplinary Longitudinal (long-term) Study of Adult Development (1,002 participants).",1.0,1.0,1.0,1.0
Q26_A2,5,"Participants were either born in 1950/52 (midlife sample, n = 502) or in 1930/32 (late-life sample, n = 500) and followed up for up to 12 years.",502 participants were born in 1950/52 (midlife sample). 500 were born in 1930/32 (late-life sample) and followed up for up to 12 years.,1.0,1.0,1.0,1.0
Q26_A2,6,"Based on bivariate latent change score regression models (adjusted for gender, education, self-rated and physician-rated health), we observed that, apart from very few exceptions, the intervariable cross-lagged associations between personality traits and cognitive abilities were generally similar between cohorts.","Based on analysis, we observed that, except for very few exceptions, the associations between personality traits and mental abilities were generally similar between groups.",0.0,1.0,1.0,1.0
Q26_A2,7,"Moreover, in case of neuroticism, extraversion, and openness, the effects of cognitive abilities on change in personality were stronger than the reversed effects.","Moreover, regarding neuroticism, extraversion, and openness, mental abilities affected change in personality stronger than vice versa.",1.0,1.0,1.0,1.0
Q26_A2,8,"Our findings thus suggest that the so far predominant perspective of personality in middle adulthood and late-life as a predictor, rather than as an outcome, of cognitive abilities needs more differentiation and reconsideration.",Our results note that the common idea of personality in middle adulthood and late-life as predicting mental abilities needs to be reconsidered.,1.0,1.0,1.0,1.0
Q27_A1,1,Background: Carpal tunnel syndrome is a common cause of neurological symptomatology.,"As background, carpal tunnel syndrome (in which a wrist nerve is pinched/compressed) is a common cause of nerve-related symptoms.",1.0,1.0,1.0,1.0
Q27_A1,2,Surgical decompression remains the treatment of choice in patients not responding to conservative therapies.,Surgical decompression (surgery to cut into and decompress the pinched wrist nerve) is the main treatment of choice for patients for whom other treatments do not work.,1.0,1.0,1.0,1.0
Q27_A1,3,The aim of this study was to assess the effectiveness of standard open decompression by analysis of symptomatic and functional improvement and to assess whether a general surgeon can still perform this operation safely.,We aim to measure how well standard open decompression works by analyzing symptom and function improvement and measure if a general surgeon can still perform the operation safely.,1.0,1.0,1.0,1.0
Q27_A1,4,Patients and methods: Patients undergoing standard open carpal tunnel release by a single general surgeon were recruited.,We recruited patients undergoing open carpal tunnel release (open decompression) by a single general surgeon.,1.0,1.0,1.0,1.0
Q27_A1,5,A self-administered Boston questionnaire was used to assess symptom severity and functional status pre- and post-surgical intervention.,We used a self-reported Boston questionnaire to measure symptom severity and functional status pre- and post-surgery.,1.0,0.0,1.0,1.0
Q27_A1,6,Results: Forty-seven patients (51 hands) underwent carpal tunnel release and 32 patients completed the questionnaire.,"For results, 47 patients (51 hands) had carpal tunnel release. 32 patients completed the questionnaire.",1.0,1.0,1.0,1.0
Q27_A1,7,"88% had a significant reduction in the symptom severity score, while improvement in function status score was achieved in 79% of patients.",88% noted a reduction in the symptom severity score. 79% noted improvement in the function status score.,0.0,1.0,1.0,1.0
Q27_A1,8,"Mean symptom severity score improved from 3.41 points preoperatively to 1.85 (p < 0.0001) points at the last follow up examination, while the mean function status score improved from 2.73 to 1.99 points (p < 0.0001).",Average symptom severity score improved from 3.41 points pre-operation to 1.85 points at the last follow up. Average function status score improved from 2.73 to 1.99 points.,0.0,1.0,1.0,1.0
Q27_A1,9,Outcome was poor in six patients with slight worsening of either symptom or function status score.,6 patients noted poor outcomes with slight worsening of either symptom or function status score.,1.0,1.0,1.0,1.0
Q27_A1,10,Three patients were treated conservatively for minor wound infection without long-term sequelae.,3 patients were treated cautiously for minor wound infection without long-term consequences.,1.0,1.0,0.0,1.0
Q27_A1,11,Discussion: Standard open carpal tunnel release still provides efficacious symptomatic relief with a low risk of associated complications when performed by a general surgeon.,Standard open carpal tunnel release still provides effective symptom relief with a low risk of associated effects when done by a general surgeon.,1.0,1.0,1.0,1.0
Q28_A2,1,"A fifty-year-old woman was admitted to our hospital because of generalized edema, progressive symptoms of fatigue and weakness of ten years' duration.","We admitted a 50-year-old woman to our hospital because of swelling, fatigue, and weakness worsening over 10 years.",1.0,1.0,1.0,1.0
Q28_A2,2,"After an uneventful third delivery, 24 years before admission, she could not lactate and developed oligomenorrhea and then amenorrhea.","After a normal third delivery, 24 years before our admission, she could not lactate and developed oligomenorrhea (infrequent menstrual periods) and then amenorrhea (lack of menstruation).",0.0,1.0,1.0,1.0
Q28_A2,3,Laboratory evaluation revealed panhypopituitarism and pituitary cell antibodies were positive.,"Lab tests showed panhypopituitarism (reduced pituitary hormone release). Also, she had antibodies targeting the pituitary.",1.0,1.0,1.0,1.0
Q28_A2,4,Both CT scans and MR images showed empty sella.,Both CT scans and MR images showed empty sella (in which the pituitary gland is flattened or smaller).,1.0,1.0,1.0,1.0
Q28_A2,5,This case is postpartum hypopituitarism without a preceding history of excessive bleeding and may be autoimmune hypophysitis.,This case is postbirth hypopituitarism (reduced pituitary hormone release) without prior excessive bleeding and may be autoimmune hypophysitis (in which the immune cell targets the pituitary gland).,0.0,1.0,1.0,1.0
Q29_A1,1,Renal artery stenosis (RAS) is the most common correctable cause of hypertension.,Renal artery stenosis (RAS) is the most common correctable cause of hypertension (high blood pressure).,1,1,1,1
Q29_A1,2,The current study was undertaken to evaluate the usefulness of color Doppler flow imaging as a screening examination in the detection of significant RAS.,We evaluate the usefulness of color Doppler flow imaging (which bounces sound waves off circulating red blood cells to measure blood flow) to screen for RAS.,1,1,1,1
Q29_A1,3,Fifty-five kidneys in 30 patients were examined with aortography and color Doppler flow imaging in a double-blind fashion.,We examined 55 kidneys in 30 patients with aortography (imaging involving dye and X-rays) and color Doppler flow imaging.,1,1,1,1
Q29_A1,4,"The peak systolic velocity (PSV) in the renal artery, the renal-aortic ratio (RAR) (ie, the ratio of the PSV in the renal artery to the PSV in the aorta), and the renal artery resistive index were determined and compared with the percentage of stenosis as determined with angiography.","We determined and compared the peak systolic velocity (PSV) - which measures top blood flow speed - in the kidney artery, the renal-aortic ratio (RAR) (the ratio of the PSV in the kidney artery to the PSV in the main blood vessel pumping blood from the heart) and renal artery resistive index (score comparing peak blood flow speed to resting blood flow speed) with the percentage of stenosis (narrowing of the blood vessel) determined with angiography (imaging blood vessels with X-rays).",1,1,1,1
Q29_A1,5,Ultrasound (US) criteria used to diagnose RAS were (a) an RAR of 3.5 or greater and/or (b) a renal artery PSV of greater than 100 cm/sec.,Ultrasound (US) scoring to diagnose RAS were (a) an RAR of at least 3.5 and/or (b) a renal artery PSV of greater than 100 centimeters (cm)/second (sec).,1,1,1,1
Q29_A1,6,Doppler tracings were obtained in 25 (69%) of 36 kidneys with a patent single renal artery.,We got Doppler results in 25 (69%) of 36 kidneys with an obvious single renal artery.,1,1,1,1
Q29_A1,7,RAR and PSV each yielded a sensitivity of 0% in the diagnosis of RAS.,RAR and PSV each yielded a sensitivity (test's ability to detect a disease) of 0% to diagnose RAS.,0,1,1,1
Q29_A1,8,Doppler tracings were obtained in three (50%) of six occluded renal arteries.,We got Doppler results in 3 (50%) of 6 blocked renal arteries.,0,1,1,1
Q29_A1,9,"Accessory arteries were present in 13 (24%) of 55 kidneys, but none were visualized with color Doppler flow imaging.","Smaller, branched-off arteries were present in 13 (24%) of 55 kidneys. None were visualized with color Doppler flow imaging.",1,1,1,1
Q29_A1,10,"The authors conclude that with current technical capability, color duplex US is not an adequate screening method for the detection of RAS.","We conclude that with current technology, color duplex US is not a proper screening method for RAS detection.",1,1,1,1
Q30_A3,1,"The acute onset of purple digits is a concerning manifestation and may represent underlying, potentially life-threatening disease.","Immediate onset of purple fingers is concerning and may represent an underlying, potentially life-threatening disease.",1.0,1.0,1.0,1.0
Q30_A3,2,"Correctly identifying the etiology of purple digits is essential to proper management, and can aid in the diagnosis of systemic disease.",Correctly identifying the cause of purple fingers is needed for proper management and can help diagnose full-body disease.,1.0,1.0,1.0,1.0
Q30_A3,3,Multiple causes of purple digits and significant overlap in clinical presentation can make diagnosis difficult.,Multiple causes of purple digits and overlap in how they look can make diagnosis difficult.,1.0,1.0,1.0,1.0
Q30_A3,4,"Despite the various causes of acute purple digits in the published literature, an algorithmic approach to the evaluation and management of the most common and alarming etiologies has yet to be established.","Despite the many causes of acute purple digits in studies, we have not established a way to evaluate and manage the most common and alarming causes.",1.0,1.0,1.0,1.0
Q30_A3,5,The initial step in evaluating a patient with purple digits is to determine if the cause is associated with hypoxemia or trauma.,The first step to evaluate a patient with purple fingers is see if the cause is associated with hypoxemia (low oxygenated blood supply) or damage.,1.0,1.0,1.0,1.0
Q30_A3,6,"If the patient is in a stable condition, the dermatologist needs to determine if the process could be related to cold exposure such as Raynaud phenomenon, acrocyanosis, pernio, cryoglobulinemia or frostbite.","If the patient is healthy, the dermatologist (skin doctor) needs to check if the process could be linked to cold exposure diseases such as Raynaud phenomenon (a disorder involving constricted blood vessels), acrocyanosis (low oxygen delivered to the finger), pernio (skin sores or bumps from low temperatures), cryoglobulinemia (a rare disorder involving inflammation of blood vessels), or frostbite.",0.0,1.0,1.0,1.0
Q30_A3,7,"If the disease occurs independent of temperature, physical examination and histological evaluation of the skin is recommended.","If the disease occurs regardless of temperature, physical exams and microscopic imaging of the skin is recommended.",1.0,1.0,1.0,1.0
Q30_A3,8,The lack of peripheral pulses are concerning for acute arterial thrombosis from peripheral vascular disease or arterial embolism.,Not having pulses in the fingers is concerning for acute arterial thrombosis (blood clotting in the arteries) from peripheral vascular disease (narrowed blood vessels) or arterial embolism (blood clotting blocking blood flow).,1.0,1.0,1.0,1.0
Q30_A3,9,"Non-blanching skin changes on the digit that lack inflammation and microthrombosis most likely represent a bleeding or platelet abnormality; however, if microthrombi are identified a more life-threatening processes such as purpura fulminans or embolic phenomenon may be occurring.","Non-disappearing skin changes on the finger that lack inflammation and microthrombosis (blood clots) most likely show a blood disorder. However, microthrombi (small blood clots) may signal a more life-threatening process like purpura fulminans or embolic phenomenon (rare blood clotting disorders).",1.0,1.0,0.0,1.0
Q30_A3,10,Evidence of blood vessel inflammation suggests a leukocytoclastic vasculitis.,Blood vessel inflammation may suggest leukocytoclastic vasculitis (a disorder involving inflammation of the blood vessel),1.0,1.0,1.0,0.0
Q30_A3,11,The patient with a purple blanching digit and normal pulses requires an extensive historical review to help determine the cause.,The patient with a non-disappearing purple finger and normal pulses needs a detailed review to help find the cause.,1.0,1.0,1.0,1.0
Q30_A3,12,This review presents an algorithmic approach to assist in the evaluation and management of the purple digit.,We present a systematic approach to help evaluate and manage the purple digit.,1.0,0.0,1.0,1.0
Q31_A10,1,"Background: Chronic health conditions and polypharmacy are common among the older population and associated with increased risks of adverse events, medicine-interactions, geriatric syndromes, falls and mortality.","For background, long-lasting health conditions and using multiple drugs are common among older adullts and associated with increased risks of harmful events, medicine-interactions, elderly disorders, falls, and death.",-1,1,1,1
Q31_A10,2,Poor nutrition is also common in older people.,Poor nutrition is also common in older people.,1,1,1,1
Q31_A10,3,Causal associations between medication use and older people's nutrient status is seldom discussed.,Causes between medication use and older people's diet is rarely discussed.,1,1,1,1
Q31_A10,4,"Objectives: The objectives of this review were to summarise the literature reporting associations between medicines commonly prescribed to older adults and nutrient deficiencies, and to discuss the clinical implications and management.",We aim to summarise past studies reporting associations between common medicines for older adults and nutrient deficiencies and discuss management.,1,1,1,1
Q31_A10,5,Methods: Medicine information resources (n = 5) were searched for information about nutrient deficiencies associated with common medicines used by older people and listed within the top 50 medicines prescribed by volume on the Australian Pharmaceutical Benefits Scheme.,We searched 5 medical databases for information about nutrient deficiencies associated with common medicines used by older people and listed within the top 50 medicines prescribed by amount on the Australian Pharmaceutical Benefits Scheme.,-1,1,1,1
Q31_A10,6,This was followed by a search for clinical studies published on PubMed from inception to April 2020.,We then searched for PubMed studies published anytime until April 2020.,1,1,1,1
Q31_A10,7,"Data was extracted, tabulated and summarised with clinical information relevant to pharmacists and clinicians involved in the care of older people taking medicines.",We reviewed data with clinical information relevant to pharmacists and clinicians involved in the care of older people taking medicines.,1,1,1,1
Q31_A10,8,Results: A total of 23 clinical studies were identified reporting medicine-induced nutrient deficiencies in older adults.,We found 23 clinical studies reporting medicine-caused nutrient deficiencies in older adults.,1,1,1,1
Q31_A10,9,"Vitamin B12, sodium, magnesium were identified as the 3 main nutrients susceptible to deficiency by medicines used to treat cardiovascular disease, neurological conditions, gastrointestinal conditions, and diabetes.","We identified Vitamin B12, sodium, magnesium as the 3 main nutrients susceptible to deficiency by medicines used to treat heart-related disease, nerve conditions, stomach conditions, and diabetes.",0,1,1,1
Q31_A10,10,The coenzyme CoQ10 was depleted by statins.,The coenzyme CoQ10 (a common antioxidant made by the body) was depleted by statins (cholesterol-lowering drugs).,1,1,1,1
Q31_A10,11,Conclusion: Certain medicines commonly prescribed to older adults are associated with nutrient deficiencies that may be clinically significant.,"In conclusion, certain medicines for older adults are associated with possibly significant nutrient deficiencies.",1,1,1,1
Q31_A10,12,"Given the high prevalence of comorbidities and polypharmacy it is possible that some of these individual drug-induced nutrient deficiencies are compounded, warranting both clinical and research attention.","Since there is a high rate of related diseases and using multiple drugs, some of these individual drug-causes nutrient deficiencies may be compounded, needing clinical and research attention.",-1,1,0,0
Q32_A2,1,"Objectives: Interictal epileptiform discharges (IEDs) have been linked to memory impairment, but the spatial and temporal dynamics of this relationship remain elusive.","Interictal epileptiform discharges (IEDs) - large electrical spikes in the brain occuring between seizures - have been related to memory impairment. However, where and when this relationship occurs is unknown.",1,1,1,1
Q32_A2,2,"In the present study, we aim to systematically characterize the brain areas and times at which IEDs affect memory.",We aim to describe the brain areas and times at which IEDs affect memory.,1,1,1,1
Q32_A2,3,Methods: Eighty epilepsy patients participated in a delayed free recall task while undergoing intracranial electroencephalography (EEG) monitoring.,80 epilepsy patients participated in a memory test while their electrical brain activity was monitored.,1,1,1,1
Q32_A2,4,We analyzed the locations and timing of IEDs relative to the behavioral data in order to measure their effects on memory.,We analyzed the locations and timing of IEDs relative to the behavioral data to measure their effects on memory.,0,0,1,1
Q32_A2,5,"Results: Overall IED rates did not correlate with task performance across subjects (r = 0.03, p = 0.8).","For results, overall IED rates did not correlate with task performance.",1,1,1,1
Q32_A2,6,"However, at a finer temporal scale, within-subject memory was negatively affected by IEDs during the encoding and recall periods of the task but not during the rest and distractor periods (p < 0.01, p < 0.001, p = 0.3, and p = 0.8, respectively).","However, at a finer timing scale, memory for each subject was negatively affected by IEDs during the learning and recall periods but not during the rest and distractor periods of the task.",-1,0,1,1
Q32_A2,7,The effects of IEDs during encoding and recall were stronger in the left hemisphere than in the right (p < 0.05).,IED effects during learning and recall were stronger in the left brain hemisphere than in the right.,1,0,1,1
Q32_A2,8,"Of six brain areas analyzed, IEDs in the inferior-temporal, medial-temporal, and parietal areas significantly affected memory (false discovery rate < 0.05).","Of the 6 brain areas analyzed, IEDs in brain areas on the side of the head and towards the top of the head affected memory.",1,1,1,1
Q32_A2,9,Significance: These findings reveal a network of brain areas sensitive to IEDs with key nodes in temporal as well as parietal lobes.,These results show a group of brain areas sensitive to IEDs with key areas in the side and top of the head.,1,1,1,1
Q32_A2,10,They also demonstrate the time-dependent effects of IEDs in this network on memory.,They also show the time-dependent effects of IEDs in this group on memory.,1,1,1,1
Q33_A9,1,"Rationale: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes long-term pulmonary sequelae in adults, but little is known about pulmonary outcomes in pediatrics.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus causing a severe lung infection, causes long-term lung consequences in adults. However, we know little about lung outcomes in children.",1.0,1.0,1.0,1.0
Q33_A9,2,Objective(s): The aim of this study was to describe long-term subjective and objective pulmonary abnormalities after SARS-CoV-2 infection in pediatric populations.,We aim to describe long-term personal and measurable lung changes after SARS-CoV-2 infection in child populations.,1.0,1.0,1.0,1.0
Q33_A9,3,"Methods: Single-center, retrospective cohort of patients seen in post-coronavirus disease 2019 (COVID-19) pulmonary clinic in 2021.",The study included a previous patient group seen in a post-coronavirus disease 2019 (COVID-19) lung clinic in 2021.,1.0,1.0,1.0,1.0
Q33_A9,4,Subjects evaluated had persistent pulmonary symptoms 4 weeks or more after initial infection.,Patients measured had lasting lung symptoms 4 weeks or more after initial infection.,1.0,1.0,1.0,1.0
Q33_A9,5,"Clinical testing included a 6-min walk test (6MWT), chest X-ray, pre- and postbronchodilator spirometry, plethysmography, and diffusion capacity.","Clinical testing included a 6-min walk test (6MWT), chest X-rays, breathing tests measuring inhalation and exhalation, tests measuring changes in volume in the body, and gas transfer rate between lungs and blood.",1.0,1.0,1.0,1.0
Q33_A9,6,Patients were followed 2-to-3-months after the initial visit with repeat testing.,We redid testing of patients 2-to-3-months after the first visit.,1.0,1.0,1.0,1.0
Q33_A9,7,The primary outcome was the presence of abnormal pulmonary function testing.,The main measure was the presence of abnormal lung function testing.,1.0,1.0,1.0,1.0
Q33_A9,8,Secondary measures included variables associated with pulmonary outcomes.,Secondary measures included lung outcomes.,1.0,1.0,0.0,1.0
Q33_A9,9,"Results: Eighty-two adolescents were seen at a median of 3.5 months postinfection, with approximately 80% reporting two or more symptoms at clinic presentation (cough, chest pain, dyspnea at rest, and exertional dyspnea).","We saw 82 adolescents around 3.5 months postinfection, with around 80% noting at least 2 symptoms seen at the clinic (cough, chest pain, shortness of breath at rest, and shortness of breath during work).",0.0,1.0,1.0,1.0
Q33_A9,10,At follow-up (~6.5 months) exertional dyspnea persisted for most (67%).,"At follow-up (~6.5 months), shortness of breath during work persisted for most (67%).",1.0,1.0,1.0,1.0
Q33_A9,11,"Spirometry was normal in 77% of patients, but 31% had a positive bronchodilator response.","Breathing tests are normal in 77% of patients. However, 31% had improved breathing after taking medication to make breathing easier.",1.0,1.0,1.0,1.0
Q33_A9,12,No abnormalities were noted on plethysmography or diffusion capacity.,We noted no abnormalities on tests measuring changes in volume in the body or gas transfer rate.,1.0,1.0,1.0,1.0
Q33_A9,13,"Clinical phenotypes identified included inhaled corticosteroid responsiveness, paradoxical vocal fold motion disorder, deconditioning, and dysautonomia.","Symptoms seen at clinic included breathing changes to inhaled steroid medication, paradoxical vocal fold motion disorder (a disease similar to asthma), adaptations to a less stressful environment, and a disorder affecting the nervous system.",0.0,1.0,1.0,1.0
Q33_A9,14,"Multivariable modeling demonstrated that obesity, anxiety, and resting dyspnea were associated with reduced 6MWT, while female sex and resting dyspnea were associated with higher Borg Dyspnea and Fatigues scores.","Obesity, anxiety, and resting shortness of breath were associated with reduced 6MWT. Gemale sex and resting shortness of breath were associated with higher shortness of breath and fatigue scores.",1.0,1.0,1.0,0.0
Q33_A9,15,Conclusions: This is the largest study to date of pediatric patients with long-term pulmonary sequelae post-COVID-19.,"In conclusion, this is the largest study to date of adolescent patients with long-term lung consequences post-COVID-19.",1.0,1.0,1.0,1.0
Q33_A9,16,Identified clinical phenotypes and risk factors warrant further study and treatment.,Identified clinical symptoms and risk factors need more study and treatment.,1.0,1.0,1.0,1.0
Q34_A5,1,Functional neurologic disorder (FND)/conversion disorder is a prevalent and disabling condition at the intersection of neurology and psychiatry.,"Functional neurologic disorder (FND)/conversion disorder - a group of movement disorders caused by changes in the brain or nervous system - is a prevailing, disabling condition affecting the nervous system and mind.",0,1,1,1
Q34_A5,2,"Clinicians often report feeling ill-equipped treating patients with FND, perpetuated by a historically limited understanding of neurobiologic disease mechanisms.",Clinicians often note feeling unprepared treating FND patients due to little understanding of its mechanisms.,1,1,1,1
Q34_A5,3,"In this review, we summarize the neuroimaging literature across the spectrum of sensorimotor FND, including functional imaging studies during rest, sensorimotor performance, and emotional-processing tasks as well as structural magnetic resonance imaging findings.","We review neuroimaging studies regarding sensorimotor FND, including structural and functional imaging during rest, sensorimotor motions, and emotional-processing tasks.",0,-1,1,1
Q34_A5,4,"Particular attention is given to studies implicating the anterior and middle cingulate cortex and related salience network structures (insula, amygdala, and periaqueductal gray) in the neurobiology of FND.",We highlight studies about the brain areas involved in attention or salience regarding the neurobiology of FND.,1,1,1,1
Q34_A5,5,"Neuroimaging studies identify cingulo-insular functional alterations during rest, motor performance, and emotion processing in FND populations.","Neuroimaging studies identify changes in the cingulo-insular (a brain area on the side of the head involved in attention) during rest, motor performance, and emotion processing in FND groups.",1,1,1,1
Q34_A5,6,"The literature also supports that patients with FND exhibit heightened amygdalar and periaqueductal gray reactivity to emotionally valenced stimuli, enhanced coupling between amygdalar and motor control areas, and increased amygdalar volumes.","FND patients show increased amygdalar volume, reactivity, and connectivity to other brain areas. The amygdala is a brain area heavily involved in emotional processing.",1,1,1,1
Q34_A5,7,"The structural neuroimaging literature also implicates cingulo-insular areas in the pathophysiology of FND, though these findings require replication and clarification.","The studies imply cingulo-insular areas are involved in FND's disease biology. However, these findings need replication and explanation.",1,1,1,1
Q34_A5,8,"While more research is needed to fully elucidate the pathophysiology of FND, salience network alterations appear present in some FND populations and can be contextualized using biopsychosocial models for FND.","While we need more research to explain the biology of FND, salience network changes are present in some FND groups and can be described with biological, psychological, and social FND models.",-1,1,1,1
Q35_A8,1,Background: It is critical to developing an accurate method for differentiating between malignant and benign solitary pulmonary nodules.,"For background, accurately identifying between malignant (harmful) and benign (harmless) solitary pulmonary nodules (single growths in the lung) is important.",0,1,1,1
Q35_A8,2,This study aimed was to establish a predicting model of lung nodules malignancy in a real-world setting.,We aim to develop a way to predict lung nodules malignancy in the real world.,1,0,1,0
Q35_A8,3,"Methods: The authors retrospectively analysed the clinical and computed tomography (CT) data of 121 patients with lung nodules, submitted to percutaneous CT-guided transthoracic biopsy, between 2014 and 2015.","We analysed the clinical and computed tomography (CT) scans of 121 patients with lung nodules, sent for biopsy (lab analysis of a small cut-out part of the nodule), between 2014 and 2015.",-1,1,1,1
Q35_A8,4,Multiple logistic regression was used to screen independent predictors for malignancy and to establish a clinical prediction model to evaluate the probability of malignancy.,We screened single predictors for malignancy to create a clinical prediction model to measure malignancy probability.,1,0,1,1
Q35_A8,5,"Results: From a total of 121 patients, 75 (62%) were men and with a mean age of 64.7 years old.","From 121 total patients, 75 (62%) were men and with an average age of 64.7 years old.",1,1,1,1
Q35_A8,6,"Multivariate logistic regression analysis identified six independent predictors of malignancy: age, gender, smoking status, current extra-pulmonary cancer, air bronchogram and nodule size (p<0.05).","We found six independent predictors of malignancy: age, gender, smoking status, current extra-pulmonary cancer (cancer from outside the lungs), air bronchogram (air-filled parts of the lung when the background is airless) and nodule size.",0,0,1,1
Q35_A8,7,The area under the curve (AUC) was 0.8573.,The detection rate was high.,1,1,1,1
Q35_A8,8,"Conclusions: The prediction model established in this study can be used to assess the probability of malignancy in the Portuguese population, thereby providing help for the diagnosis of lung nodules and the selection of follow-up interventions.","In conclusion, our prediction model can help measure malignancy probability in the Portuguese population for diagnosis of lung nodules and selecting follow-up treatments.",0,0,1,1
Q36_A4,1,"Purpose: As obesity rates continue to climb, the notion that overconsumption reflects an underlying 'food addiction' (FA) has become increasingly influential.","As obesity rates climb, the idea that overconsumption is an underlying 'food addiction' (FA) has become more popular.",1.0,1.0,1.0,1.0
Q36_A4,2,"An increasingly popular theory is that sugar acts as an addictive agent, eliciting neurobiological changes similar to those seen in drug addiction.","An popular theory is that sugar acts as an addictive agent, causing brain changes similar to those seen in drug addiction.",1.0,1.0,1.0,0.0
Q36_A4,3,"In this paper, we review the evidence in support of sugar addiction.",We review studies supporting sugar addiction.,1.0,1.0,1.0,1.0
Q36_A4,4,"Methods: We reviewed the literature on food and sugar addiction and considered the evidence suggesting the addictiveness of highly processed foods, particularly those with high sugar content.","We reviewed studies on food and sugar addiction and those about the addictiveness of highly processed foods, especially high-sugar ones.",0.0,1.0,1.0,1.0
Q36_A4,5,We then examined the addictive potential of sugar by contrasting evidence from the animal and human neuroscience literature on drug and sugar addiction.,We then examined the addictiveness of sugar by checking evidence from animal and human brain research on drug and sugar addiction.,1.0,1.0,1.0,1.0
Q36_A4,6,"Results: We find little evidence to support sugar addiction in humans, and findings from the animal literature suggest that addiction-like behaviours, such as bingeing, occur only in the context of intermittent access to sugar.","For results, we find little evidence supporting sugar addiction in humans. Animal findings suggest that addiction-like behaviours, such as bingeing (excess eating), occur only with irregular access to sugar.",1.0,1.0,1.0,1.0
Q36_A4,7,"These behaviours likely arise from intermittent access to sweet tasting or highly palatable foods, not the neurochemical effects of sugar.","These behaviours likely came from irregular access to sweet tasting or highly palatable foods, not the brain effects of sugar.",1.0,1.0,1.0,1.0
Q36_A4,8,"Conclusion: Given the lack of evidence supporting it, we argue against a premature incorporation of sugar addiction into the scientific literature and public policy recommendations.","In conclusion, due to lack of evidence, we argue against the idea of sugar addiction for scientific study and public policy recommendations.",1.0,1.0,1.0,1.0
Q37_A2,1,"When used appropriately, immunization can effectively prevent many infections and diseases.","When vaccines are used correctly, they can help protect people from getting sick with many different infections and diseases. This is called immunization.",1.0,1.0,1.0,1.0
Q37_A2,2,"Some vaccines, such as that for polio, are believed to produce lifelong immunity.","Certain vaccines, like the one for polio, are believed to provide protection for a person's entire life.",1.0,1.0,1.0,1.0
Q37_A2,3,"Others, such as those for tetanus and diphtheria, may require that a booster injection be given upon exposure to assure full immunity.","Some vaccines, like the ones for tetanus and diphtheria, may need to be given again as a booster shot to make sure a person is fully protected, especially if they are exposed to the disease.",1.0,1.0,1.0,1.0
Q37_A2,4,"Still others, such as that for influenza, confer immunity for only a limited time.","There are some vaccines, like the one for influenza, that only provide protection for a short period of time.",1.0,1.0,1.0,1.0
Q37_A2,5,"Inoculation is not without risk, particularly in immunosuppressed, allergic, febrile, or pregnant patients.","Vaccines can be risky, especially for people who have weakened immune systems, allergies, high fevers, or are pregnant.",1.0,1.0,1.0,1.0
Q37_A2,6,"However, in otherwise healthy patients, serious sequelae are so rare that they are far overshadowed by the enormous benefits of immunization.","In people who are generally healthy, bad side effects from vaccines are extremely uncommon and not as important as the many good things that vaccines do to help prevent illnesses.",0.0,1.0,1.0,1.0
Q38_A10,1,Multiple myeloma is an incurable haematological cancer.,Multiple myeloma is a type of blood cancer that cannot be cured.,1.0,1.0,1.0,1.0
Q38_A10,2,The increase in targeted therapies has improved the number of myeloma patients achieving a complete response and improved progression-free survival following therapy.,The use of specific treatments has helped more multiple myeloma patients to recover fully and have a longer time without the disease getting worse.,1.0,1.0,1.0,1.0
Q38_A10,3,"However, a low level of disease or minimal residual disease (MRD) still persists which contributes to the inevitable relapse in myeloma patients.","In some cases, even though treatments have improved, a small amount of cancer cells may still be left in the body, called minimal residual disease (MRD). This can increase the chances of the cancer coming back in patients with myeloma.",1.0,1.0,1.0,1.0
Q38_A10,4,"MRD has been attributed to the presence of dormant myeloma cells and their subsequent reactivation, which is controlled by the microenvironment and specialised niches within the bone marrow.","MRD is associated with dormant cancer cells in the body, which can become active again and cause a relapse in myeloma patients. The microenvironment and specialized areas in the bone marrow play a role in controlling this.",1.0,1.0,1.0,1.0
Q38_A10,5,"This contributes to the evasion of the immune system and chemotherapy, eventually leading to relapse.","This helps cancer cells escape from the immune system and chemotherapy, which can lead to the disease coming back (relapse).",1.0,1.0,1.0,1.0
Q38_A10,6,"The growth of myeloma tumours are heavily dependent on environmental stimuli from the bone marrow microenvironment, and this plays a key role in myeloma progression.","The growth of myeloma tumors is heavily influenced by signals from the bone marrow environment, which plays a crucial role in the progression of the disease.",1.0,1.0,1.0,1.0
Q38_A10,7,The bone microenvironment also plays a critical role in myeloma bone disease and the development of skeletal-related events.,The small environment in bones is important for the growth of multiple myeloma and the development of bone problems.,1.0,1.0,1.0,1.0
Q38_A10,8,This review focuses on the bone marrow microenvironment in relation to myeloma pathogenesis and cancer dormancy.,This article talks about how the environment in the bone marrow affects the growth of myeloma and the way cancer cells can remain dormant (not active).,1.0,1.0,1.0,1.0
Q38_A10,9,"Moreover, it reviews the current therapies targeting the bone microenvironment to treat myeloma and myeloma bone disease.",This review discusses current treatments for myeloma and myeloma bone disease that target the bone microenvironment.,1.0,1.0,1.0,1.0
Q38_A10,10,"Lastly, it identifies novel therapeutic targets for myeloma treatment and the associated bone disease.",The review looks at new targets for treatment of myeloma and related bone disease.,1.0,1.0,1.0,1.0
Q39_A8,1,"Breastfed infants have a growth pattern that is different from formula-fed infants, which is regarded as the optimal growth pattern.",Formula-fed infants have a preferred growth pattern compared to breastfed infants. Breastfed infants have a different growth pattern.,1.0,1.0,1.0,1.0
Q39_A8,2,"Breastfed infants increase more in weight, length, and BMI during the first 2-3 months of life and then have a slower growth velocity up to 12 months.","Breastfed babies grow more rapidly in weight, length, and BMI during their first 2-3 months of life but then experience slower growth up to the age of 12 months.",0.0,0.0,1.0,1.0
Q39_A8,3,They also have a higher accumulation of fat during early infancy.,Breastfed infants tend to store more fat during their early months of life.,1.0,1.0,1.0,1.0
Q39_A8,4,"Breastfed infants have lower levels of circulating IGF-I and insulin, which could be part of the explanation of their growth pattern.","Breastfed infants have fewer hormones in their body that can affect growth and insulin levels, which could be a reason why they grow differently.",1.0,1.0,1.0,1.0
Q39_A8,5,Many studies and meta-analyses have examined the association between breastfeeding and later obesity.,Numerous studies have explored the association between breastfeeding and obesity in the future.,1.0,0.0,1.0,1.0
Q39_A8,6,"Most find a moderate reduction in the risk of later obesity, but it has been argued that this could be biased due to residual confounding and reverse causation.","Most studies indicate a slightly lower risk of obesity later in life for breastfed infants. However, some argue that this may not be entirely accurate due to other factors or a lack of causation between the two events.",1.0,1.0,1.0,1.0
Q39_A8,7,"From studies in low- and middle-income countries randomizing women to breastfeeding promotion, there was only little effect on early growth.",Research conducted in low- and middle-income countries indicates that promoting breastfeeding among women has only a small effect on early growth.,1.0,1.0,1.0,1.0
Q39_A8,8,"Recent studies have found associations between breast milk composition (total fat, protein, human milk oligosaccharides, adiponectin, leptin, and insulin) and growth.","New studies have discovered connections between breast milk ingredients, such as fat and protein, and an infant's growth.",1.0,1.0,1.0,1.0
Q39_A8,9,"However, the studies are few, and the results are inconsistent.","There have been a small number of studies about the link between breast milk composition and growth, but the results are not always the same.",1.0,1.0,1.0,1.0
Q39_A8,10,"More studies, including studies of maternal factors influencing breast milk composition, are needed to better understand how breastfeeding influences current and later growth and thereby short- and long-term health.",We need more research to understand how breastfeeding affects a child's growth in the short and long term. We should also look into how a mother's health may affect the nutrients in her breast milk.,1.0,1.0,1.0,1.0
Q40_A1,1,"Constipation is a disorder of gastrointestinal motility characterized by difficult or decreased bowel movements, and is a common condition in Western countries.",Constipation is when your gut doesn't move things through it properly. This can cause trouble or a decrease in bowel movements. It is a widespread problem in the Western world.,1.0,1.0,1.0,1.0
Q40_A1,2,Laxatives are the most common strategy for managing constipation.,The usual way to treat constipation is by using laxatives.,1.0,1.0,1.0,1.0
Q40_A1,3,"However, long-term use of some laxatives may be associated with harmful side-effects including increased constipation and fecal impaction.","But, taking certain laxatives for a long time may have harmful effects like making constipation worse and causing fecal impaction.",1.0,1.0,1.0,1.0
Q40_A1,4,"Abdominal massage, once an accepted method of treating constipation, is no longer standard of care, but may be a desirable therapy for this condition because it is inexpensive, non-invasive, free of harmful side-effects, and can be performed by patients themselves.","In the past, doctors used abdominal massage to treat constipation. It's not commonly used anymore, but some people still find it helpful. Abdominal massage is cheap, doesn't hurt your body, and you can do it yourself.",1.0,1.0,1.0,1.0
Q40_A1,5,"However, until recently, evidence for its effectiveness was not strong enough to make a recommendation for its use in constipated patients.","But until recently, there wasn't enough proof to say for sure that abdominal massage helps people with constipation.",1.0,1.0,1.0,1.0
Q40_A1,6,"In 1999, Ernst reviewed all available controlled clinical trials, and found that there was no sound evidence for the effectiveness of abdominal massage in the treatment of chronic constipation.","In 1999, Ernst looked at all the research that existed and saw that there wasn't enough good evidence to show that abdominal massage helps people who have constipation all the time.",0.0,1.0,1.0,1.0
Q40_A1,7,"This article reviews scientific evidence from 1999 to the present, regarding abdominal massage as an intervention for chronic constipation.",This article looks at all the research from 1999 until now to see if abdominal massage helps people who have constipation all the time.,1.0,1.0,1.0,1.0
Q40_A1,8,"Since that time, studies have demonstrated that abdominal massage can stimulate peristalsis, decrease colonic transit time, increase the frequency of bowel movements in constipated patients, and decrease the feelings of discomfort and pain that accompany it.","New research shows that abdominal massage can help your muscles move better, make bowel movements happen faster, and make them happen more often. It can also reduce pain and discomfort.",1.0,1.0,1.0,1.0
Q40_A1,9,There is also good evidence that massage can stimulate peristalsis in patients with post-surgical ileus.,There is strong evidence that massage can help people who have lost control of their intestines' muscles due to surgery by making their muscles move better.,1.0,1.0,1.0,1.0
Q40_A1,10,"Individual case reports show that massage has been effective for patients with constipation due to a variety of diagnosed physiologic abnormalities, as well as in patients with long-term functional constipation.","Records show that massage has helped people with constipation for many different reasons, as well as those who have had it for a long time and don't know why.",1.0,1.0,1.0,1.0
